Menu
Back to Journals » Neuropsychiatric Disease and Treatment » Volume 15
Neuropsychiatric Disease and Treatment
ISSN: 1178-2021
- View all (4097)
- Volume 19, 2023 (240)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Archive: Volume 15, 2019
Neuroprotective effect and mechanism of baicalin on Parkinson’s disease model induced by 6-OHDA
Tu L, Wu ZY, Yang XL, Zhang Q, Gu R, Wang Q, Tian T, Yao H, Qu X, Tian JY
Neuropsychiatric Disease and Treatment 2019, 15:3615-3625
Published Date: 3 January 2020
The Relationship Between Course of Illness and β-Endorphin Plasma Levels in Patients with Schizophrenia
Urban-Kowalczyk M, Kotlicka-Antczak M, Strzelecki D, Rudecka E, Śmigielski J
Neuropsychiatric Disease and Treatment 2019, 15:3609-3614
Published Date: 3 January 2020
Therapeutic Dose of Amitriptyline for Older Patients with Burning Mouth Syndrome
Suga T, Takenoshita M, Watanabe T, Tu TTH, Mikuzuki L, Hong C, Miura K, Yoshikawa T, Nagamine T, Toyofuku A
Neuropsychiatric Disease and Treatment 2019, 15:3599-3607
Published Date: 30 December 2019
MicroRNA-Based Biomarkers in the Diagnosis and Monitoring of Therapeutic Response in Patients with Depression
Xu YY, Xia QH, Xia QR, Zhang XL, Liang J
Neuropsychiatric Disease and Treatment 2019, 15:3583-3597
Published Date: 27 December 2019
Methylenetetrahydrofolate Reductase Gene Variants Confer Potential Vulnerability to Autism Spectrum Disorder in a Saudi Community
Arab AH, Elhawary NA
Neuropsychiatric Disease and Treatment 2019, 15:3569-3581
Published Date: 27 December 2019
Managing Functional Neurological Disorders: Protocol of a Cohort Study on Psychogenic Non-Epileptic Seizures Study
Altalib HH, Galluzzo D, Argraves S, Goulet J, Bornovski Y, Cheung KH, Jackson-Shaheed E, Tolchin B, Fenton BT, Pugh MJ
Neuropsychiatric Disease and Treatment 2019, 15:3557-3568
Published Date: 27 December 2019
Widely Impaired White Matter Integrity and Altered Structural Brain Networks in Psychogenic Non-Epileptic Seizures
Sone D, Sato N, Ota M, Kimura Y, Matsuda H
Neuropsychiatric Disease and Treatment 2019, 15:3549-3555
Published Date: 24 December 2019
Real-World Effectiveness and Safety of Antipsychotics in Individuals at Clinical High-Risk for Psychosis: Study Protocol for a Prospective Observational Study (ShangHai at Risk for Psychosis-Phase 2)
Wu G, Gan R, Li Z, Xu L, Tang X, Wei Y, Hu Y, Cui H, Li H, Tang Y, Hui L, Liu X, Li C, Wang J, Zhang T
Neuropsychiatric Disease and Treatment 2019, 15:3541-3548
Published Date: 24 December 2019
Psychache and Suicidal History in Patients with Obsessive-Compulsive Disorder
Demirkol ME, Namlı Z, Eriş Davul Ö, Karaytuğ MO, Tamam L, Yılmaz H
Neuropsychiatric Disease and Treatment 2019, 15:3531-3539
Published Date: 24 December 2019
Type C Personality and Depression Among Newly Diagnosed Breast Cancer Patients: The Mediating Role of Sense of Coherence
Wei M, Guo L, Zhu Y, Guo Y, Yv S, Namassevayam G, Xue W, Li J, Li L, Shen Z, Yv J, Zhu Z, Wang W, Liu Y, Zhao J, Chen F
Neuropsychiatric Disease and Treatment 2019, 15:3519-3529
Published Date: 24 December 2019
Pilot Validation Study of the Japanese Translation of the Brief Negative Symptoms Scale (BNSS)
Hashimoto N, Toyomaki A, Oka M, Takanobu K, Okubo R, Narita H, Kitagawa K, Udo N, Maeda T, Watanabe S, Oyanagi Y, Miyazaki A, Ito K, Kusumi I
Neuropsychiatric Disease and Treatment 2019, 15:3511-3518
Published Date: 23 December 2019
Posttraumatic Stress Disorder and Associated Factors Among Drivers Surviving Road Traffic Crashes in Southwest Ethiopia
Alenko A, Berhanu H, Tareke AA, Reta W, Bariso M, Mulat E, Kenenisa C, Debebe W, Tolesa K, Girma S
Neuropsychiatric Disease and Treatment 2019, 15:3501-3509
Published Date: 24 December 2019
Decreased Vascular Pulsatility in Alzheimer’s Disease Dementia Measured by Transcranial Color-Coded Duplex Sonography
Ortner M, Hauser C, Schmaderer C, Muggenthaler C, Hapfelmeier A, Sorg C, Diehl-Schmid J, Kurz A, Förstl H, Ikenberg B, Kotliar K, Poppert H, Grimmer T
Neuropsychiatric Disease and Treatment 2019, 15:3487-3499
Published Date: 20 December 2019
Correlation of Health-Related Quality of Life in Clinically Stable Outpatients with Schizophrenia
Domenech C, Pastore A, Altamura AC, Bernasconi C, Corral R, Elkis H, Evans J, Malla A, Margari F, Krebs MO, Nordstroem AL, Zink M, Haro JM
Neuropsychiatric Disease and Treatment 2019, 15:3475-3486
Published Date: 20 December 2019
Exploration of Treatment-Resistant Schizophrenia Subtypes Based on a Survey of 204 US Psychiatrists
Correll CU, Brevig T, Brain C
Neuropsychiatric Disease and Treatment 2019, 15:3461-3473
Published Date: 19 December 2019
Co-Occurring Psychiatric and Substance Use Disorders: Clinical Survey Among a Rural Cohort of Italian Patients
Milano G, Vergani HM, Cattedra S, Carrozzino R, Mattioli F, Robbiano L, Martelli A
Neuropsychiatric Disease and Treatment 2019, 15:3453-3459
Published Date: 18 December 2019
Thromboelastography with Platelet Mapping Detects Platelet Dysfunction in Patients with Aneurysmal Subarachnoid Hemorrhage with Rebleeding
He Q, Zhou Y, Liu C, Zhang X, Huang N, Wang F, Liu G, Cheng Y, Xie Z
Neuropsychiatric Disease and Treatment 2019, 15:3443-3451
Published Date: 16 December 2019
Electroacupuncture Promoting Axonal Regeneration in Spinal Cord Injury Rats via Suppression of Nogo/NgR and Rho/ROCK Signaling Pathway
Xiao WP, Ding LLQ, Min YJ, Yang HY, Yao HH, Sun J, Zhou X, Zeng XB, Yu W
Neuropsychiatric Disease and Treatment 2019, 15:3429-3442
Published Date: 13 December 2019
The Effect of Counseling on Stigma in Psychiatric Patients Receiving Electroconvulsive Therapy: A Clinical Trial Study
Sadeghian E, Rostami P, Shamsaei F, Tapak L
Neuropsychiatric Disease and Treatment 2019, 15:3419-3427
Published Date: 6 December 2019
Comparative Study of Cognitive Function Between Treatment-Resistant Depressive Patients and First-Episode Depressive Patients
Rao D, Xu G, Lu Z, Liang H, Lin K, Tang M
Neuropsychiatric Disease and Treatment 2019, 15:3411-3417
Published Date: 9 December 2019
Experiences Of Immigrant Parents In Sweden Participating In A Community Assessment And Intervention Program For Preschool Children With Autism
Nilses Å, Jingrot M, Linnsand P, Gillberg C, Nygren G
Neuropsychiatric Disease and Treatment 2019, 15:3397-3410
Published Date: 6 December 2019
Meta-Analysis of Clipping versus Coiling for the Treatment of Unruptured Middle Cerebral Artery Aneurysms: Direct Comparison of Procedure-Related Complications
Xin W, Xin Q, Yang X
Neuropsychiatric Disease and Treatment 2019, 15:3387-3395
Published Date: 5 December 2019
Validity and Reliability Study of the Chinese Traditional Version of the Devereux Early Childhood Assessment for Toddlers DECA T
Liang SHY, Chou JY, Wu YY, Lee CP, Kelsen BA, Lee YC
Neuropsychiatric Disease and Treatment 2019, 15:3375-3385
Published Date: 5 December 2019
Clinical Characteristics of Women with ADHD in Japan
Hayashi W, Suzuki H, Saga N, Arai G, Igarashi R, Tokumasu T, Ota H, Yamada H, Takashio O, Iwanami A
Neuropsychiatric Disease and Treatment 2019, 15:3367-3374
Published Date: 4 December 2019
Resting-State Functional MRI Study: Connection Strength of Brain Networks in DR Patients
Li L, Dai H, Ke J, Shi C, Jiang N, Yang CM
Neuropsychiatric Disease and Treatment 2019, 15:3359-3366
Published Date: 5 December 2019
Effect of Benzo[a]pyrene-DNA Adduct in Cord Blood on the Neurodevelopment of 12-Month-Old Infants in Qingdao City
Zhang Y, Yang Y, Zhang Q, Cui J, Rahaman A, Huang XR, Su Y, Gao R, Wang B, Baloch Z
Neuropsychiatric Disease and Treatment 2019, 15:3351-3357
Published Date: 2 December 2019
Employment-Related Factors of Forensic Psychiatric Outpatients with Psychotic Disorders
Takeda K, Sugawara N, Yamada Y, Nagata T, Kashiwagi H, Kono T, Hirabayashi N, Okada T
Neuropsychiatric Disease and Treatment 2019, 15:3341-3350
Published Date: 2 December 2019
Cornel Iridoid Glycoside Protects Against White Matter Lesions Induced by Cerebral Ischemia in Rats via Activation of the Brain-Derived Neurotrophic Factor/Neuregulin-1 Pathway
Wang M, Hua X, Niu H, Sun Z, Zhang L, Li Y, Zhang L, Li L
Neuropsychiatric Disease and Treatment 2019, 15:3327-3340
Published Date: 2 December 2019
Adaptive Affect: The Nature of Anxiety and Depression
Morris DW
Neuropsychiatric Disease and Treatment 2019, 15:3323-3326
Published Date: 2 December 2019
An Inpatient Observational Study: Characteristics And Outcomes Of Avoidant/Restrictive Food Intake Disorder (ARFID) In Children And Adolescents In Japan
Kurotori I, Shioda K, Abe T, Kato R, Ishikawa S, Suda S
Neuropsychiatric Disease and Treatment 2019, 15:3313-3321
Published Date: 27 November 2019
Reversible Affective Symptoms and Attention Executive Control Network Impairment Following Thyroid Function Normalization in Hyperthyroidism
Yuan L, Zhang Y, Luan D, Xu X, Yang Q, Zhao S, Zhou Z
Neuropsychiatric Disease and Treatment 2019, 15:3305-3312
Published Date: 26 November 2019
Empathy In Neurodegenerative Diseases: A Systematic Review
Pick E, Kleinbub JR, Mannarini S, Palmieri A
Neuropsychiatric Disease and Treatment 2019, 15:3287-3304
Published Date: 22 November 2019
Current Perspectives On The Role Of The Ketogenic Diet In Epilepsy Management
Goswami JN, Sharma S
Neuropsychiatric Disease and Treatment 2019, 15:3273-3285
Published Date: 25 November 2019
Transcranial Photobiomodulation For The Management Of Depression: Current Perspectives
Askalsky P, Iosifescu DV
Neuropsychiatric Disease and Treatment 2019, 15:3255-3272
Published Date: 22 November 2019
Vagus Nerve Stimulation For Treatment Resistant Depression: Case Series Of Six Patients - Retrospective Efficacy And Safety Observation After One Year Follow Up
Kucia K, Merk W, Zapalowicz K, Medrala T
Neuropsychiatric Disease and Treatment 2019, 15:3247-3254
Published Date: 25 November 2019
Frequency-Specific Abnormalities Of Functional Homotopy In Alcohol Dependence: A Resting-State Functional Magnetic Resonance Imaging Study
Guo L, Zhou F, Zhang N, Kuang H, Feng Z
Neuropsychiatric Disease and Treatment 2019, 15:3231-3245
Published Date: 19 November 2019
Alterations Of Glycerophospholipid And Fatty Acyl Metabolism In Multiple Brain Regions Of Schizophrenia Microbiota Recipient Mice
Liang W, Huang Y, Tan X, Wu J, Duan J, Zhang H, Yin B, Li Y, Zheng P, Wei H, Xie P
Neuropsychiatric Disease and Treatment 2019, 15:3219-3229
Published Date: 19 November 2019
The Association Between Eating Green Vegetables Every Day And Mild Cognitive Impairment: A Community-Based Cross-Sectional Study In Shanghai
Li W, Sun L, Yue L, Li G, Xiao S
Neuropsychiatric Disease and Treatment 2019, 15:3213-3218
Published Date: 18 November 2019
Conversion From The Korean Dementia Screening Questionnaire To The Informant Questionnaire On Cognitive Decline In The Elderly
Yeo TY, Kim K, Park MH
Neuropsychiatric Disease and Treatment 2019, 15:3205-3211
Published Date: 19 November 2019
Psychometric Properties Of The Persian Version Of The Memory Impact Questionnaire In Older Adults
Ebadi A, Ebtekar F, Parizad N, Afkhamzadeh A, Dalvand S, Ghanei Gheshlagh R
Neuropsychiatric Disease and Treatment 2019, 15:3197-3204
Published Date: 14 November 2019
Profile Of Patients With Advanced Parkinson’s disease Suitable For Device-Aided Therapies: Restrospective Data Of A Large Cohort Of Romanian Patients
Szász JA, Constantin VA, Orbán-Kis K, Rácz A, Bancu LA, Georgescu D, Szederjesi J, Mihály I, Fárr AM, Kelemen K, Vajda T, Szatmári S
Neuropsychiatric Disease and Treatment 2019, 15:3187-3195
Published Date: 13 November 2019
Prediction Of Playfulness By Pretend Play, Severity Of Autism Behaviors, And Verbal Comprehension In Children With Autism Spectrum Disorder
Chen KL, Chen CT, Lin CH, Huang CY, Lee YC
Neuropsychiatric Disease and Treatment 2019, 15:3177-3186
Published Date: 13 November 2019
Traditional Chinese Medicine Shenmayizhi Decoction Ameliorates Memory And Cognitive Impairment Induced By Scopolamine Via Preventing Hippocampal Cholinergic Dysfunction In Rats
Wu Q, Cao Y, Liu M, Liu F, Brantner AH, Yang Y, Wei Y, Zhou Y, Wang Z, Ma L, Wang F, Pei H, Li H
Neuropsychiatric Disease and Treatment 2019, 15:3167-3176
Published Date: 12 November 2019
No Association Between Human Immunodeficiency Virus Infections And Dementia: A Nationwide Cohort Study In Taiwan
Yang CC, Chien WC, Chung CH, Liu YP, Yeh CB, Chen KH, Yang SN, Chang HA, Kao YC, Lu WC, Tzeng NS
Neuropsychiatric Disease and Treatment 2019, 15:3155-3166
Published Date: 12 November 2019
Treatment Of Magnesium-L-Threonate Elevates The Magnesium Level In The Cerebrospinal Fluid And Attenuates Motor Deficits And Dopamine Neuron Loss In A Mouse Model Of Parkinson’s disease
Shen Y, Dai L, Tian H, Xu R, Li F, Li Z, Zhou J, Wang L, Dong J, Sun L
Neuropsychiatric Disease and Treatment 2019, 15:3143-3153
Published Date: 11 November 2019
Mindfulness-Based Intervention For Nurses In AIDS Care In China: A Pilot Study
Pan C, Wang H, Chen M, Cai Y, Xiao C, Tang Q, Koniak-Griffin D
Neuropsychiatric Disease and Treatment 2019, 15:3131-3141
Published Date: 8 November 2019
Attention Deficit Hyperactivity Disorder And Borderline Personality Disorder In Adults: A Review Of Their Links And Risks
Weiner L, Perroud N, Weibel S
Neuropsychiatric Disease and Treatment 2019, 15:3115-3129
Published Date: 8 November 2019
The Efficacy, Feasibility And Acceptability Of A Remotely Accessible Use Of CIRCuiTS, A Computerized Cognitive Remediation Therapy Program For Schizophrenia: A Pilot Study
Palumbo D, Mucci A, Giordano GM, Piegari G, Aiello C, Pietrafesa D, Annarumma N, Chieffi M, Cella M, Galderisi S
Neuropsychiatric Disease and Treatment 2019, 15:3103-3113
Published Date: 8 November 2019
Is visuomotor training an effective intervention for children with autism spectrum disorders?
Arabi M, Saberi Kakhki A, Sohrabi M, Soltani Kouhbanani S, Jabbari Nooghabi M
Neuropsychiatric Disease and Treatment 2019, 15:3089-3102
Published Date: 8 November 2019
Improvement Of Frontal Lobe Dysfunction And White Matter Integrity By rTMS In Treatment-Resistant Depression
Tateishi H, Nishihara M, Kawaguchi A, Matsushima J, Murakawa T, Haraguchi Y, Kunitake Y, Maekawa T, Kato TA, Asami T, Mizoguchi Y, Monji A
Neuropsychiatric Disease and Treatment 2019, 15:3079-3087
Published Date: 6 November 2019
Sex Differences In Psychoeducation For Patients With Depression: A Comparison Of Frequency And Efficacy Of Psychoeducation
Tomita T, Kudo S, Sugawara N, Fujii A, Tsuruga K, Sato Y, Ishioka M, Nakamura K, Yasui-Furukori N
Neuropsychiatric Disease and Treatment 2019, 15:3069-3078
Published Date: 6 November 2019
Differential Diagnosis Of Multiple-System Atrophy With Parkinson’s Disease By External Anal- And Urethral-Sphincter Electromyography
Qiu F, Wang K, Li T, Song D, Wang Z, Zhang H, Liu J, Ren M, Qi X
Neuropsychiatric Disease and Treatment 2019, 15:3061-3067
Published Date: 5 November 2019
Correlations And Correlates Of Post-Traumatic Growth And Post-Traumatic Stress Symptoms In Patients With Breast Cancer
Chen HM, Chen VCH, Hsiao HP, Weng YP, Hsu YT, Weng JC, Su JA, Chen YL
Neuropsychiatric Disease and Treatment 2019, 15:3051-3060
Published Date: 1 November 2019
Ginkgo biloba Extract Reduces Hippocampus Inflammatory Responses, Improves Cardiac Functions And Depressive Behaviors In A Heart Failure Mouse Model
Zhang L, Liu J, Ge Y, Liu M
Neuropsychiatric Disease and Treatment 2019, 15:3041-3050
Published Date: 29 October 2019
Effect Of An Extra-Virgin Olive Oil Intake On The Delay Of Cognitive Decline: Role Of Secoiridoid Oleuropein?
Klimova B, Novotný M, Kuca K, Valis M
Neuropsychiatric Disease and Treatment 2019, 15:3033-3040
Published Date: 29 October 2019
Reversion From Mild Cognitive Impairment To Normal Cognition: False-Positive Error Or True Restoration Thanks To Cognitive Control Ability?
Chung JY, Yoon HJ, Kim H, Choi KY, Lee JJ, Lee KH, Seo EH
Neuropsychiatric Disease and Treatment 2019, 15:3021-3032
Published Date: 25 October 2019
Association study of genetic variants of the ANGPTL3 gene and susceptibility to ischemic stroke
Gong Q, Ye L, Gui H, Liu J, Li H, Sun Q
Neuropsychiatric Disease and Treatment 2019, 15:3015-3020
Published Date: 24 October 2019
Transcranial Direct-Current Stimulation (tDCS) Versus Venlafaxine ER In The Treatment Of Depression: A Randomized, Double-Blind, Single-Center Study With Open-Label, Follow-Up
Bares M, Brunovsky M, Stopkova P, Hejzlar M, Novak T
Neuropsychiatric Disease and Treatment 2019, 15:3003-3014
Published Date: 23 October 2019
Stigmasterol Exerts Neuro-Protective Effect Against Ischemic/Reperfusion Injury Through Reduction Of Oxidative Stress And Inactivation Of Autophagy
Sun J, Li X, Liu J, Pan X, Zhao Q
Neuropsychiatric Disease and Treatment 2019, 15:2991-3001
Published Date: 18 October 2019
Evaluation Of Subjective Cognitive Function Using The Cognitive Complaints In Bipolar Disorder Rating Assessment (COBRA) In Japanese Adults
Toyoshima K, Inoue T, Masuya J, Ichiki M, Fujimura Y, Kusumi I
Neuropsychiatric Disease and Treatment 2019, 15:2981-2990
Published Date: 18 October 2019
Improvement of mental health among Chinese plateau military personnel, 1993–2017: a cross-temporal meta-analysis of the Symptom Checklist-90
Zhao M, Feng Z, Yang G
Neuropsychiatric Disease and Treatment 2019, 15:2971-2980
Published Date: 18 October 2019
Efficacy Of Dual-Task Training With Two Different Priorities Instructional Sets On Gait Parameters In Patients With Chronic Stroke
Sengar S, Raghav D, Verma M, Alghadir AH, Iqbal A
Neuropsychiatric Disease and Treatment 2019, 15:2959-2969
Published Date: 17 October 2019
Nicotine consumption during the prodromal phase of schizophrenia – a review of the literature
Gogos A, Skokou M, Ferentinou E, Gourzis P
Neuropsychiatric Disease and Treatment 2019, 15:2943-2958
Published Date: 16 October 2019
Soluble epoxide hydrolase inhibition enhances anti-inflammatory and antioxidative processes, modulates microglia polarization, and promotes recovery after ischemic stroke
Yeh CF, Chuang T, Hung YW, Lan MY, Tsai CH, Huang HX, Lin YY
Neuropsychiatric Disease and Treatment 2019, 15:2927-2941
Published Date: 15 October 2019
Difficulties In Emotion Regulation During Rehabilitation For Alcohol Addiction: Correlations With Metacognitive Beliefs About Alcohol Use And Relapse Risk
Ottonello M, Fiabane E, Pistarini C, Spigno P, Torselli E
Neuropsychiatric Disease and Treatment 2019, 15:2917-2925
Published Date: 14 October 2019
CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients
Lin Y, Yang X, Lv J, Liu X, Wang S
Neuropsychiatric Disease and Treatment 2019, 15:2909-2915
Published Date: 11 October 2019
Bipolar Spectrum Disorders And Associated Factors Among Adults Attending An Antiretroviral Therapy Clinic In Gedeo Zone Health Centers, Southern Ethiopia [Corrigendum]
Belayneh Z, Alemu W, Mekuriaw B, Abebe Z
Neuropsychiatric Disease and Treatment 2019, 15:2907-2908
Published Date: 10 October 2019
Clozapine As Transformative Treatment In Bipolar Patients
Wilkowska A, Cubała WJ
Neuropsychiatric Disease and Treatment 2019, 15:2901-2905
Published Date: 9 October 2019
Changes In Plasma NPY, IL-1β And Hypocretin In People Who Died By Suicide
Lu J, Li S, Li H, Mou T, Zhou L, Huang B, Huang M, Xu Y
Neuropsychiatric Disease and Treatment 2019, 15:2893-2900
Published Date: 10 October 2019
Is Autism Inborn And Lifelong For Everyone?
Whiteley P, Carr K, Shattock P
Neuropsychiatric Disease and Treatment 2019, 15:2885-2891
Published Date: 7 October 2019
Evaluation Of Mean Platelet Volume, Red Cell Distributed Width And Neutrophil To Lymphocyte Ratio In Conversion Disorder
Büyükaslan H, Asoğlu M
Neuropsychiatric Disease and Treatment 2019, 15:2879-2884
Published Date: 4 October 2019
Associations Of Personality Traits With The Capacity-Performance Discrepancy Of Functional Outcome In Patients With Schizophrenia
Uchino T, Nemoto T, Yamaguchi T, Katagiri N, Tsujino N, Murakami Y, Tanaka K, Mizuno M
Neuropsychiatric Disease and Treatment 2019, 15:2869-2877
Published Date: 3 October 2019
Cerebrospinal Fluid Proteomics For Identification Of α2-Macroglobulin As A Potential Biomarker To Monitor Pharmacological Therapeutic Efficacy In Dopamine Dictated Disease States Of Parkinson’s Disease And Schizophrenia
Gupta AK, Pokhriyal R, Khan MI, Kumar DR, Gupta R, Chadda RK, Ramachandran R, Goyal V, Tripathi M, Hariprasad G
Neuropsychiatric Disease and Treatment 2019, 15:2853-2867
Published Date: 2 October 2019
Diffusion Tensor Imaging And Tractography In Autistic, Dysphasic, And Healthy Control Children
Hrdlicka M, Sanda J, Urbanek T, Kudr M, Dudova I, Kickova S, Pospisilova L, Mohaplova M, Maulisova A, Krsek P, Kyncl M, Blatny M, Komarek V
Neuropsychiatric Disease and Treatment 2019, 15:2843-2852
Published Date: 3 October 2019
Victimization In Childhood Affects Depression In Adulthood Via Neuroticism: A Path Analysis Study
Tachi S, Asamizu M, Uchida Y, Katayama S, Naruse M, Masuya J, Ichiki M, Inoue T
Neuropsychiatric Disease and Treatment 2019, 15:2835-2841
Published Date: 3 October 2019
Comparative Diagnostic Accuracy Of ACE-III And MoCA For Detecting Mild Cognitive Impairment: A Letter To The Editor [Letter]
Richards E, Knowles O
Neuropsychiatric Disease and Treatment 2019, 15:2833-2834
Published Date: 30 September 2019
Assessment of current clinical practices for major depression in Japan using a web-based questionnaire
Hori H, Yamato K
Neuropsychiatric Disease and Treatment 2019, 15:2821-2832
Published Date: 1 October 2019
Risk-Taking Behaviours In Relation To Attention Deficit And Hyperactivity Disorder In Iranian Male Workers: A Latent Class Analysis [Letter]
Knowles O, Richards E
Neuropsychiatric Disease and Treatment 2019, 15:2819-2820
Published Date: 27 September 2019
Public Awareness, Beliefs, And Attitudes Toward Bipolar Disorder In Saudi Arabia
Alosaimi FD, AlAteeq DA, Bin Hussain SI, Alhenaki RS, Bin Salamah AA, AlModihesh NA
Neuropsychiatric Disease and Treatment 2019, 15:2809-2818
Published Date: 27 September 2019
Association Of Cigarette Smoking With Anxiety, Depression, And Suicidal Ideation Among Brazilian Adolescents
Slomp FM, Bara TS, Picharski GL, Cordeiro ML
Neuropsychiatric Disease and Treatment 2019, 15:2799-2808
Published Date: 25 September 2019
An Evidence-Based Review On The Use Of Perampanel For The Treatment Of Focal-Onset Seizures In Pediatric Patients
Dozières-Puyravel B, Auvin S
Neuropsychiatric Disease and Treatment 2019, 15:2789-2798
Published Date: 24 September 2019
The Risk Of Seizure-Related Hospitalization Among Older Adults On Levetiracetam Monotherapy: A Retrospective Comparative Cohort Study
Alzahrani H, Almalag HM, AlRuthia Y, Al-hussain F, Balkhi B, Almutairi L, Algasem R, De Vol EB, Almarzouqi MR, Alsemari A
Neuropsychiatric Disease and Treatment 2019, 15:2781-2788
Published Date: 24 September 2019
Monitoring And Managing Depression In Adolescents With Epilepsy: Current Perspectives
Coppola G, Operto FF, Matricardi S, Verrotti A
Neuropsychiatric Disease and Treatment 2019, 15:2773-2780
Published Date: 24 September 2019
Subthreshold Depression Needs A Prime Time In Old Age Psychiatry? A Narrative Review Of Current Evidence
Biella MM, Borges MK, Strauss J, Mauer S, Martinelli JE, Aprahamian I
Neuropsychiatric Disease and Treatment 2019, 15:2763-2772
Published Date: 23 September 2019
Transcranial magnetic stimulation for the treatment of anxiety disorder
Rodrigues PA, Zaninotto AL, Neville IS, Hayashi CY, Brunoni AR, Teixeira MJ, Paiva WS
Neuropsychiatric Disease and Treatment 2019, 15:2743-2761
Published Date: 23 September 2019
Catatonia in Down syndrome: systematic approach to diagnosis, treatment and outcome assessment based on a case series of seven patients
Miles JH, Takahashi N, Muckerman J, Nowell KP, Ithman M
Neuropsychiatric Disease and Treatment 2019, 15:2723-2741
Published Date: 20 September 2019
Differentiation Between Dementia With Lewy Bodies And Alzheimer’s Disease Using Voxel-Based Morphometry Of Structural MRI: A Multicenter Study
Matsuda H, Yokoyama K, Sato N, Ito K, Nemoto K, Oba H, Hanyu H, Kanetaka H, Mizumura S, Kitamura S, Shinotoh H, Shimada H, Suhara T, Terada H, Nakatsuka T, Kawakatsu S, Hayashi H, Asada T, Ono T, Goto T, Shigemori K
Neuropsychiatric Disease and Treatment 2019, 15:2715-2722
Published Date: 19 September 2019
Analysis of correlation between cerebral perfusion and KIM score of white matter lesions in patients with Alzheimer’s disease
Li RR, He YS, Liu M, Nie ZY, Huang LH, Lu Z, Jin LJ, Li YX
Neuropsychiatric Disease and Treatment 2019, 15:2705-2714
Published Date: 18 September 2019
Effects Of Modified Mindfulness-Based Stress Reduction (MBSR) On The Psychological Health Of Adolescents With Subthreshold Depression: A Randomized Controlled Trial
Zhang JY, Ji XZ, Meng LN, Cai YJ
Neuropsychiatric Disease and Treatment 2019, 15:2695-2704
Published Date: 17 September 2019
Co-administration of aspirin and adipose-derived stem cell conditioned medium improves the functional recovery of the optic pathway in a lysolecithin-induced demyelination model
Galeshi A, Ghasemi-Kasman M, Feizi F, Davoodian N, Zare L, Abedian Z
Neuropsychiatric Disease and Treatment 2019, 15:2681-2694
Published Date: 17 September 2019
Galuteolin attenuates cerebral ischemia/reperfusion injury in rats via anti-apoptotic, anti-oxidant, and anti-inflammatory mechanisms
Cheng X, Zhang F, Li J, Wang G
Neuropsychiatric Disease and Treatment 2019, 15:2671-2680
Published Date: 16 September 2019
Transcranial direct current stimulation for Obsessive-Compulsive Disorder: patient selection and perspectives
da Silva RMF, Brunoni AR, Miguel EC, Shavitt RG
Neuropsychiatric Disease and Treatment 2019, 15:2663-2669
Published Date: 16 September 2019
Plasma levels of IL-6 in patients with untreated major depressive disorder: comparison with catecholamine metabolites
Yoshimura R, Kishi T, Iwata N
Neuropsychiatric Disease and Treatment 2019, 15:2655-2661
Published Date: 13 September 2019
Comparative diagnostic accuracy of ACE-III and MoCA for detecting mild cognitive impairment
Wang BR, Zheng HF, Xu C, Sun Y, Zhang YD, Shi JQ
Neuropsychiatric Disease and Treatment 2019, 15:2647-2653
Published Date: 13 September 2019
Assessing effectiveness of aripiprazole lauroxil vs placebo for the treatment of schizophrenia using number needed to treat and number needed to harm
Citrome L, Du Y, Weiden PJ
Neuropsychiatric Disease and Treatment 2019, 15:2639-2646
Published Date: 12 September 2019
Disrupted Brain Entropy And Functional Connectivity Patterns Of Thalamic Subregions In Major Depressive Disorder
Xue SW, Wang D, Tan Z, Wang Y, Lian Z, Sun Y, Hu X, Wang X, Zhou X
Neuropsychiatric Disease and Treatment 2019, 15:2629-2638
Published Date: 11 September 2019
C-reactive protein is associated with severity of thought and language dysfunction in patients with schizophrenia
Chang CH, Lane HY, Liu CY, Cheng PC, Chen SJ, Lin CH
Neuropsychiatric Disease and Treatment 2019, 15:2621-2627
Published Date: 10 September 2019
Differences in oxytocin and vasopressin levels in individuals suffering from the autism spectrum disorders vs general population – a systematic review
Wilczyński KM, Zasada I, Siwiec A, Janas-Kozik M
Neuropsychiatric Disease and Treatment 2019, 15:2613-2620
Published Date: 10 September 2019
Borderline personality disorder, trauma, and the hypothalamus–pituitary–adrenal axis
Thomas N, Gurvich C, Kulkarni J
Neuropsychiatric Disease and Treatment 2019, 15:2601-2612
Published Date: 9 September 2019
Brivaracetam in the treatment of epilepsy: a review of clinical trial data
Feyissa AM
Neuropsychiatric Disease and Treatment 2019, 15:2587-2600
Published Date: 9 September 2019
Repetitive transcranial magnetic stimulation significantly influences the eating behavior in depressive patients
Jaššová K, Albrecht J, Čerešňáková S, Papežová H, Anders M
Neuropsychiatric Disease and Treatment 2019, 15:2579-2586
Published Date: 6 September 2019
Evaluating optic nerve diameter as a possible biomarker for disability in patients with multiple sclerosis
Koraysha NA, Kishk N, Hassan A, Samy El Gendy NM, Shehata HS, Al-Azayem SA, Kamal YS
Neuropsychiatric Disease and Treatment 2019, 15:2571-2578
Published Date: 6 September 2019
A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future
Citrome L, McEvoy JP, Todtenkopf MS, McDonnell D, Weiden PJ
Neuropsychiatric Disease and Treatment 2019, 15:2559-2569
Published Date: 5 September 2019
Efficacy of ginkgo biloba extract as augmentation of venlafaxine in treating post-stroke depression
Liang ZH, Jia YB, Wang ML, Li ZR, Li M, Yun YL, Zhu RX
Neuropsychiatric Disease and Treatment 2019, 15:2551-2557
Published Date: 3 September 2019
Relationship between the timing of relapse and plasma drug levels following discontinuation of cariprazine treatment in patients with schizophrenia: indirect comparison with other second-generation antipsychotics after treatment discontinuation
Correll CU, Jain R, Meyer JM, Periclou A, Carrothers T, Barabássy Á, Patel M, Earley W
Neuropsychiatric Disease and Treatment 2019, 15:2537-2550
Published Date: 30 August 2019
Affective theory of mind in Parkinson’s disease: the effect of cognitive performance
Romosan AM, Dehelean L, Romosan RS, Andor M, Bredicean AC, Simu MA
Neuropsychiatric Disease and Treatment 2019, 15:2521-2535
Published Date: 30 August 2019
Risk taking behaviors in relation to Attention Deficit and Hyperactivity Disorder in Iranian male workers: a latent class analysis
Abbasi-Ghahramanloo A, Janani L, Malakouti SK, Rabetian M, Rimaz S
Neuropsychiatric Disease and Treatment 2019, 15:2513-2520
Published Date: 28 August 2019
Dementia care in the Danube Region. A multi-national expert survey
Mehrabian S, Schwarzkopf L, Auer S, Holmerova I, Kramberger MG, Boban M, Stefanova E, Tudose C, Bachinskaya N, Kovács T, Koranda P, Kunchev T, Traykov L, Diehl-Schmid J, Milecka K, Kurz A
Neuropsychiatric Disease and Treatment 2019, 15:2503-2511
Published Date: 29 August 2019
Disrupted topological organization of human brain connectome in diabetic retinopathy patients
Huang X, Tong Y, Qi CX, Xu YT, Dan HD, Shen Y
Neuropsychiatric Disease and Treatment 2019, 15:2487-2502
Published Date: 27 August 2019
Complex effects of childhood abuse, affective temperament, and subjective social status on depressive symptoms of adult volunteers from the community
Higashiyama M, Hayashida T, Sakuta K, Fujimura Y, Masuya J, Ichiki M, Tanabe H, Kusumi I, Inoue T
Neuropsychiatric Disease and Treatment 2019, 15:2477-2485
Published Date: 27 August 2019
The association between cortisol:C-reactive protein ratio and depressive fatigue is a function of CRP rather than cortisol
Sharpley CF, Bitsika V, McMillan ME, Jesulola E, Agnew LL
Neuropsychiatric Disease and Treatment 2019, 15:2467-2475
Published Date: 27 August 2019
The Effect of Eye Movement Desensitization and Reprocessing (EMDR) on the severity of suicidal thoughts in patients with major depressive disorder: a randomized controlled trial
Fereidouni Z, Behnammoghadam M, Jahanfar A, Dehghan A
Neuropsychiatric Disease and Treatment 2019, 15:2459-2466
Published Date: 27 August 2019
Association between ADORA2A gene polymorphisms and schizophrenia in the North Chinese Han population
Miao J, Liu L, Yan C, Zhu X, Fan M, Yu P, Ji K, Huang Y, Wang Y, Zhu G
Neuropsychiatric Disease and Treatment 2019, 15:2451-2458
Published Date: 28 August 2019
Clinical improvement following vitamin D3 supplementation in children with chronic tic disorders
Li HH, Xu ZD, Wang B, Feng JY, Dong HY, Jia FY
Neuropsychiatric Disease and Treatment 2019, 15:2443-2450
Published Date: 26 August 2019
Clinical characteristics and magnetic resonance imaging findings in nine patients with nonalcoholic Wernicke’s encephalopathy: a retrospective study
Liu YL, Xiao WM, Liang MQ, Wu ZQ, Wang YZ, Qu JF, Chen YK
Neuropsychiatric Disease and Treatment 2019, 15:2433-2441
Published Date: 26 August 2019
A single-nucleotide polymorphism influences brain morphology in drug-naïve patients with major depressive disorder
Katsuki A, Kakeda S, Watanabe K, Igata R, Otsuka Y, Kishi T, Nguyen L, Ueda I, Iwata N, Korogi Y, Yoshimura R
Neuropsychiatric Disease and Treatment 2019, 15:2425-2432
Published Date: 23 August 2019
The neuroprotective mechanism of 2-arachidonoylglycerol 2-AG against non-caspase-dependent apoptosis in mice hippocampal neurons following MCAO
Zhong HY, Yang Z, Qiu Z, Lei SQ, Xia ZY
Neuropsychiatric Disease and Treatment 2019, 15:2417-2424
Published Date: 23 August 2019
Aspects of cognitive performance relating to Theory of Mind (ToM) among people diagnosed with Post-Traumatic Stress Disorder (PTSD) [Retraction]
Altunbas FD, Onen Unsalver B, Yasar AB
Neuropsychiatric Disease and Treatment 2019, 15:2415-2416
Published Date: 22 August 2019
Conditioned taste aversion memory extinction temporally induces insular cortical BDNF release and inhibits neuronal apoptosis
Liu DW, Ma L, Zhang XH, Wang YY
Neuropsychiatric Disease and Treatment 2019, 15:2403-2414
Published Date: 22 August 2019
Functional capacity as a predictor of postoperative delirium in transurethral resection of prostate patients in Northeast Brazil
Braga ILS, Castelo-Filho J, Pinheiro RSB, de Azevedo RB, Ponte AT, da Silveira RA, Braga-Neto P, Campos AR
Neuropsychiatric Disease and Treatment 2019, 15:2395-2401
Published Date: 22 August 2019
Thymosin β4 prevents oxygen-glucose deprivation/reperfusion-induced injury in rat cortical neurons
Zhang Z, Liu S, Huang S
Neuropsychiatric Disease and Treatment 2019, 15:2385-2393
Published Date: 22 August 2019
Abnormal intrinsic functional activity in patients with cervical spondylotic myelopathy a resting state fMRI study
Kuang C, Zha Y
Neuropsychiatric Disease and Treatment 2019, 15:2371-2383
Published Date: 21 August 2019
Development of point-of-care testing devices to improve clozapine prescribing habits and patient outcomes
Kalaria SN, Kelly DL
Neuropsychiatric Disease and Treatment 2019, 15:2365-2370
Published Date: 20 August 2019
Rare compound heterozygous missense SPATA7 variations and risk of schizophrenia; whole-exome sequencing in a consanguineous family with affected siblings, follow-up sequencing and a case-control study
Igeta H, Watanabe Y, Morikawa R, Ikeda M, Otsuka I, Hoya S, Koizumi M, Egawa J, Hishimoto A, Iwata N, Someya T
Neuropsychiatric Disease and Treatment 2019, 15:2353-2363
Published Date: 19 August 2019
Administration of troxerutin and cerebroprotein hydrolysate injection alleviates cerebral ischemia/reperfusion injury by down-regulating caspase molecules
Sui R, Zang L, Bai Y
Neuropsychiatric Disease and Treatment 2019, 15:2345-2352
Published Date: 19 August 2019
Advances in the diagnosis of exosomal miRNAs in ischemic stroke
Yu P, Chen W
Neuropsychiatric Disease and Treatment 2019, 15:2339-2343
Published Date: 19 August 2019
Use of the Functioning Assessment Short Test (FAST) in defining functional recovery in bipolar I disorder. Post-hoc analyses of long-term studies of aripiprazole once monthly as maintenance treatment
Madera J, Such P, Zhang P, Baker RA, Grande I
Neuropsychiatric Disease and Treatment 2019, 15:2325-2338
Published Date: 15 August 2019
Patient-reported depression severity and cognitive symptoms as determinants of functioning in patients with major depressive disorder: a secondary analysis of the 2-year prospective PERFORM study
Haro JM, Hammer-Helmich L, Saragoussi D, Ettrup A, Larsen KG
Neuropsychiatric Disease and Treatment 2019, 15:2313-2323
Published Date: 13 August 2019
Psychological status of nursing survivors in China and its associated factors: 6 years after the 2008 Sichuan earthquake
Liao J, Ma X, Gao B, Zhang M, Zhang Y, Liu M, Li X
Neuropsychiatric Disease and Treatment 2019, 15:2301-2311
Published Date: 14 August 2019
Disorder-specific dysfunction in dorsal anterior cingulate cortex and parietal cortex during cognitive reappraisal in anxiety disorder [Letter]
Wang HY, Zhang BW, Li XL
Neuropsychiatric Disease and Treatment 2019, 15:2299-2300
Published Date: 12 August 2019
Macrocytosis among patients with heroin use disorder
Ng MH, Chen VCH, Ting H, Lin TY, Chang SH, Gossop M
Neuropsychiatric Disease and Treatment 2019, 15:2293-2298
Published Date: 12 August 2019
Genetic polymorphisms in Sox17 associated with intracranial aneurysm in Chinese Han people: a genotype-phenotype study [Erratum]
Li M, Wang W, Zhang L, Xin W, Zhao Y, Huan L, Yu J, Zhang H, Zhang J, Yang S, Liang D, Yang W, Yang X
Neuropsychiatric Disease and Treatment 2019, 15:2291-2292
Published Date: 12 August 2019
Thyroid functions in patients with bipolar disorder and the impact of quetiapine monotherapy: a retrospective, naturalistic study
Li C, Lai J, Huang T, Han Y, Du Y, Xu Y, Hu S
Neuropsychiatric Disease and Treatment 2019, 15:2285-2290
Published Date: 9 August 2019
Examining the safety, efficacy, and patient acceptability of inhaled loxapine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults
Faden J, Citrome L
Neuropsychiatric Disease and Treatment 2019, 15:2273-2283
Published Date: 7 August 2019
The burden of suicidal ideation across Europe: a cross-sectional survey in five countries
Jaffe DH, Rive B, Denee TR
Neuropsychiatric Disease and Treatment 2019, 15:2257-2271
Published Date: 7 August 2019
Insula H-coil deep transcranial magnetic stimulation in severe and enduring anorexia nervosa (SE-AN): a pilot study
Knyahnytska YO, Blumberger DM, Daskalakis ZJ, Zomorrodi R, Kaplan AS
Neuropsychiatric Disease and Treatment 2019, 15:2247-2256
Published Date: 6 August 2019
Microglial activation and neurobiological alterations in experimental autoimmune prostatitis-induced depressive-like behavior in mice
Du HX, Chen XG, Zhang L, Liu Y, Zhan CS, Chen J, Zhang Y, Yu ZQ, Zhang J, Yang HY, Zhong K, Liang CZ
Neuropsychiatric Disease and Treatment 2019, 15:2231-2245
Published Date: 6 August 2019
Reduced plasma orexin-A levels in patients with bipolar disorder
Tsuchimine S, Hattori K, Ota M, Hidese S, Teraishi T, Sasayama D, Hori H, Noda T, Yoshida S, Yoshida F, Kunugi H
Neuropsychiatric Disease and Treatment 2019, 15:2221-2230
Published Date: 6 August 2019
Comparison of serum B12, folate and homocysteine concentrations in children with autism spectrum disorder or attention deficit hyperactivity disorder and healthy controls
Yektaş Ç, Alpay M, Tufan AE
Neuropsychiatric Disease and Treatment 2019, 15:2213-2219
Published Date: 6 August 2019
Impact of non-motor symptoms in Parkinson’s disease: a PMDAlliance survey
Hermanowicz N, Jones SA, Hauser RA
Neuropsychiatric Disease and Treatment 2019, 15:2205-2212
Published Date: 5 August 2019
Efficacy of low-dose D2/D3 partial agonist pramipexole on neuroleptic-induced extrapyramidal symptoms and symptoms of schizophrenia: a stage-1 open-label pilot study
Weng JJ, Wang LH, Zhu H, Xu WR, Wei YM, Wang ZY, Yu WJ, Li HF
Neuropsychiatric Disease and Treatment 2019, 15:2195-2203
Published Date: 7 August 2019
Orthostatic hypotension and dementia incidence: links and implications
Robertson AD, Udow SJ, Espay AJ, Merola A, Camicioli R, Lang AE, Masellis M
Neuropsychiatric Disease and Treatment 2019, 15:2181-2194
Published Date: 2 August 2019
Effects of creative expression therapy on Chinese elderly patients with dementia: an exploratory randomized controlled trial
Lin R, Chen HY, Li H, Li J
Neuropsychiatric Disease and Treatment 2019, 15:2171-2180
Published Date: 30 July 2019
Association between IL-6 and metabolic syndrome in schizophrenia patients treated with second-generation antipsychotics
Fang X, Wang Y, Chen Y, Ren J, Zhang C
Neuropsychiatric Disease and Treatment 2019, 15:2161-2170
Published Date: 29 July 2019
Social communication deficits and restricted repetitive behavior symptoms in Tourette syndrome
Eapen V, McPherson S, Karlov L, Nicholls L, Črnčec R, Mulligan A
Neuropsychiatric Disease and Treatment 2019, 15:2151-2160
Published Date: 26 July 2019
Atypical antipsychotics for Parkinson’s disease psychosis: a systematic review and meta-analysis
Zhang H, Wang L, Fan Y, Yang L, Wen X, Liu Y, Liu Z
Neuropsychiatric Disease and Treatment 2019, 15:2137-2149
Published Date: 29 July 2019
Different diagnostic criteria for periodic leg movements in patients with obstructive sleep apnea after continuous positive airway pressure titration
Huang CY, Yu CC
Neuropsychiatric Disease and Treatment 2019, 15:2129-2136
Published Date: 24 July 2019
Alterations of amplitude of low-frequency fluctuation in treatment-resistant versus non-treatment-resistant depression patients
Zhang A, Li G, Yang C, Liu P, Wang Y, Kang L, Wang Y, Zhang K
Neuropsychiatric Disease and Treatment 2019, 15:2119-2128
Published Date: 25 July 2019
Auditory verbal hallucinations in schizophrenia: current perspectives in brain stimulation treatments
Nathou C, Etard O, Dollfus S
Neuropsychiatric Disease and Treatment 2019, 15:2105-2117
Published Date: 24 July 2019
Impaired cognition in geriatric patients with relation to earlier life mood disorder and traumatic brain injury: a hypothesis
Tobe EH
Neuropsychiatric Disease and Treatment 2019, 15:2101-2104
Published Date: 24 July 2019
Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review
Xu H, Zhuang X
Neuropsychiatric Disease and Treatment 2019, 15:2087-2099
Published Date: 22 July 2019
Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia
Gupta AK, Pokhriyal R, Das U, Khan MI, Ratna Kumar D, Gupta R, Chadda RK, Ramachandran R, Goyal V, Tripathi M, Hariprasad G
Neuropsychiatric Disease and Treatment 2019, 15:2073-2085
Published Date: 19 July 2019
Frequent nightmares in Chinese patients undergoing methadone maintenance therapy: prevalence, correlates, and their association with functional impairment
Zhong BL, Xu YM, Xie WX, Lu J
Neuropsychiatric Disease and Treatment 2019, 15:2063-2072
Published Date: 18 July 2019
The role of aberrant salience and alexithymia in psychotic experiences of non-treatment-seeking adolescent immigrants compared with natives
Pozza A
Neuropsychiatric Disease and Treatment 2019, 15:2057-2061
Published Date: 18 July 2019
An intervention targeting social, communication and daily activity skills in children and adolescents with Down syndrome and autism: a pilot study
Wester Oxelgren U, Westerlund J, Myrelid Å, Annerén G, Johansson L, Åberg M, Gustafsson J, Fernell E
Neuropsychiatric Disease and Treatment 2019, 15:2049-2056
Published Date: 18 July 2019
Relationships between sleep patterns and metabolic profile in patients maintained on antipsychotics: a cross-sectional comparative study
Kiwan N, Mahfoud Z, Ghuloum S, Yehya A, Hammoudeh S, Hani Y, Chamali R, Amro I, Mook-Kanamori D, Al-Amin H
Neuropsychiatric Disease and Treatment 2019, 15:2035-2047
Published Date: 19 July 2019
Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization
Mar J, Arrospide A, Soto-Gordoa M, Iruin Á, Tainta M, Gabilondo A, Mar-Barrutia L, Calvo M, Mateos M, Ibarrondo O
Neuropsychiatric Disease and Treatment 2019, 15:2027-2034
Published Date: 17 July 2019
Aspects of cognitive performance relating to Theory of Mind (ToM) among people diagnosed with Post-Traumatic Stress Disorder (PTSD)
Altunbas FD, Onen Unsalver B, Yasar AB
Neuropsychiatric Disease and Treatment 2019, 15:2015-2025
Published Date: 17 July 2019
Early-onset Alzheimer’s disease patient with prion (PRNP) p.Val180Ile mutation
Bagyinszky E, Kang MJ, Pyun J, Giau VV, An SSA, Kim S
Neuropsychiatric Disease and Treatment 2019, 15:2003-2013
Published Date: 16 July 2019
Simvastatin pretreatment ameliorates t-PA–induced hemorrhage transformation and MMP-9/TIMP-1 imbalance in thromboembolic cerebral ischemic rats
Yin B, Li DD, Xu SY, Huang H, Lin J, Sheng HS, Fang JH, Song JN, Zhang M
Neuropsychiatric Disease and Treatment 2019, 15:1993-2002
Published Date: 16 July 2019
Development of the 12-item questionnaire for quantitative assessment of depressive mixed state (DMX-12)
Shinzato H, Koda M, Nakamura A, Kondo T
Neuropsychiatric Disease and Treatment 2019, 15:1983-1991
Published Date: 15 July 2019
Psychological factors associated with smoking and quitting: addiction map of Turkey study
Ünübol H, Hızlı Sayar G
Neuropsychiatric Disease and Treatment 2019, 15:1971-1982
Published Date: 11 July 2019
Toward a personalized therapy for panic disorder: preliminary considerations from a work in progress
Caldirola D, Perna G
Neuropsychiatric Disease and Treatment 2019, 15:1957-1970
Published Date: 11 July 2019
Heart rate variability and incidence of depression during the first six months following first myocardial infarction
Wilkowska A, Rynkiewicz A, Wdowczyk J, Landowski J, Cubała WJ
Neuropsychiatric Disease and Treatment 2019, 15:1951-1956
Published Date: 10 July 2019
UPLC-Q-TOF-MS profiling of the hippocampus reveals metabolite biomarkers for the impact of Dl-3-n-butylphthalide on the lipopolysaccharide-induced rat model of depression
Geng C, Guo Y, Qiao Y, Zhang J, Chen D, Han W, Yang M, Jiang P
Neuropsychiatric Disease and Treatment 2019, 15:1939-1950
Published Date: 10 July 2019
Factors related to lithium blood concentrations in Chinese Han patients with bipolar disorder
Xu YY, Xia QH, Liang J, Cao Y, Shan F, Liu Y, Yan CY, Xia QR
Neuropsychiatric Disease and Treatment 2019, 15:1929-1937
Published Date: 10 July 2019
Exercise training increases spatial memory via reducing contralateral hippocampal NMDAR subunits expression in intracerebral hemorrhage rats
Zheng S, Zhang F, Liu Q, Jian R, Yang M
Neuropsychiatric Disease and Treatment 2019, 15:1921-1928
Published Date: 9 July 2019
Apolipoprotein E e4 allele is associated with extrapyramidal symptoms in Alzheimer’s disease
Chang YP, Chou MC, Lai CL, Chien I, Yang YH
Neuropsychiatric Disease and Treatment 2019, 15:1915-1919
Published Date: 9 July 2019
Dopaminergic pathway and primary visual cortex are involved in the freezing of gait in Parkinson’s disease: a PET-CT study
Zhou Y, Zhao J, Hou Y, Su Y, Chan P, Wang Y
Neuropsychiatric Disease and Treatment 2019, 15:1905-1914
Published Date: 10 July 2019
Febrile infection-related epilepsy syndrome (FIRES): prevalence, impact and management strategies
Serino D, Santarone ME, Caputo D, Fusco L
Neuropsychiatric Disease and Treatment 2019, 15:1897-1903
Published Date: 9 July 2019
A patient with Korsakoff syndrome of psychiatric and alcoholic etiology presenting as DSM-5 mild neurocognitive disorder [Corrigendum]
Nikolakaros G, Kurki T, Myllymäki A, Ilonen T
Neuropsychiatric Disease and Treatment 2019, 15:1895-1896
Published Date: 9 July 2019
Depression and associated factors among patients with tuberculosis in Ethiopia: a cross-sectional study
Molla A, Mekuriaw B, Kerebih H
Neuropsychiatric Disease and Treatment 2019, 15:1887-1893
Published Date: 8 July 2019
Developmental coordination disorder and dysgraphia: signs and symptoms, diagnosis, and rehabilitation
Biotteau M, Danna J, Baudou É, Puyjarinet F, Velay JL, Albaret JM, Chaix Y
Neuropsychiatric Disease and Treatment 2019, 15:1873-1885
Published Date: 8 July 2019
Antipsychotics and risk of natural death in patients with schizophrenia
Chen Y, Yang X, Qin X, Yang Q, Fan H, Li J, Song X, Xu S, Guo W, Deng W, Wang Q, Li T, Ma X
Neuropsychiatric Disease and Treatment 2019, 15:1863-1871
Published Date: 5 July 2019
Short-term adverse effects of the apolipoprotein E ϵ4 allele over language function and executive function in healthy older adults
Li W, Qiu Q, Sun L, Li X, Xiao S
Neuropsychiatric Disease and Treatment 2019, 15:1855-1861
Published Date: 10 July 2019
Validation of the Chinese version of the Health Cognitions Questionnaire in Chinese college students
Dai L, Xu Z, Yin M, Wang X, Deng Y
Neuropsychiatric Disease and Treatment 2019, 15:1845-1854
Published Date: 5 July 2019
Resting-state functional magnetic resonance imaging (fMRI) and functional connectivity density mapping in patients with corneal ulcer
Zhu F, Tang L, Zhu P, Lin Q, Yuan Q, Shi W, Li B, Ye L, Min Y, Su T, Shao Y
Neuropsychiatric Disease and Treatment 2019, 15:1833-1844
Published Date: 5 July 2019
Impact of psychiatric comorbidity on the severity, short-term functional outcome, and psychiatric complications after acute stroke
Hoyer C, Schmidt HL, Kranaster L, Alonso A
Neuropsychiatric Disease and Treatment 2019, 15:1823-1831
Published Date: 4 July 2019
Ginaton improves neurological function in ischemic stroke rats via inducing autophagy and maintaining mitochondrial homeostasis
Li X, Zhang D, Bai Y, Xiao J, Jiao H, He R
Neuropsychiatric Disease and Treatment 2019, 15:1813-1822
Published Date: 3 July 2019
QT and P-wave dispersion during the manic phase of bipolar disorder
Gurok MG, Korkmaz H, Yıldız S, Bakış D, Atmaca M
Neuropsychiatric Disease and Treatment 2019, 15:1805-1811
Published Date: 3 July 2019
Patients’ experiences of long-acting injectable antipsychotics: a qualitative study
Chiu LL, Liu CH, Chu CL, Lin HL, Lii SC
Neuropsychiatric Disease and Treatment 2019, 15:1797-1804
Published Date: 3 July 2019
An update on the anxiolytic and neuroprotective properties of etifoxine: from brain GABA modulation to a whole-body mode of action
Nuss P, Ferreri F, Bourin M
Neuropsychiatric Disease and Treatment 2019, 15:1781-1795
Published Date: 3 July 2019
Impact of serotonin transporter gene on rTMS augmentation of SSRIs for obsessive compulsive disorder
Zhang K, Fan X, Yuan J, Yin J, Su H, Hashimoto K, Wang G
Neuropsychiatric Disease and Treatment 2019, 15:1771-1779
Published Date: 2 July 2019
Review: brain neurobiology of gambling disorder based on rodent models
Quintero Garzola GC
Neuropsychiatric Disease and Treatment 2019, 15:1751-1770
Published Date: 2 July 2019
Restless arms syndrome: prevalence, impact, and management strategies
Ruppert E
Neuropsychiatric Disease and Treatment 2019, 15:1737-1750
Published Date: 1 July 2019
Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China
Wang G, Si TM, Li L, Fang Y, Wang CX, Wang LN, Tan KHX, Ettrup A, Eriksen HLF, Luo S, Ge L
Neuropsychiatric Disease and Treatment 2019, 15:1723-1736
Published Date: 1 July 2019
Association between mitochondrial DNA and cognitive impairment in schizophrenia: study protocol for a Mexican population
García-de la Cruz DD, Juárez-Rojop IE, Tovilla-Zárate CA, Martínez-Magaña JJ, Genis-Mendoza AD, Nicolini H, González-Castro TB, Guzmán-Priego CG, López-Martínez NA, Hernández-Cisneros JA, Caballero-Prado F
Neuropsychiatric Disease and Treatment 2019, 15:1717-1722
Published Date: 28 June 2019
Stereoelectroencephalography in epilepsy, cognitive neurophysiology, and psychiatric disease: safety, efficacy, and place in therapy
Youngerman BE, Khan FA, McKhann GM
Neuropsychiatric Disease and Treatment 2019, 15:1701-1716
Published Date: 28 June 2019
The level of IL-6 was associated with sleep disturbances in patients with major depressive disorder
Wang M, Wei J, Yang X, Ni P, Wang Y, Zhao L, Deng W, Guo W, Wang Q, Li T, Ma X
Neuropsychiatric Disease and Treatment 2019, 15:1695-1700
Published Date: 27 June 2019
Long-term efficacy and safety of paliperidone palmitate once-monthly in Chinese patients with recent-onset schizophrenia
Si T, Zhuo J, Feng Y, Lu H, Hong D, Zhang L
Neuropsychiatric Disease and Treatment 2019, 15:1685-1694
Published Date: 27 June 2019
Reduction in apathy following epilepsy surgery
Mah L, Swearer J, Phillips CA, Benjamin S
Neuropsychiatric Disease and Treatment 2019, 15:1679-1684
Published Date: 28 June 2019
The role of long noncoding RNA in traumatic brain injury
Li Z, Han K, Zhang D, Chen J, Xu Z, Hou L
Neuropsychiatric Disease and Treatment 2019, 15:1671-1677
Published Date: 28 June 2019
The effect of aripiprazole once-monthly on personal and social functioning: post hoc analyses of acute and long-term studies
Peters-Strickland T, Baker RA, Such P, Zhang P, Madera JJ
Neuropsychiatric Disease and Treatment 2019, 15:1659-1669
Published Date: 24 June 2019
Quality of life in euthymic patients with unipolar major depressive disorder and bipolar disorder
Bo Q, Tian L, Li F, Mao Z, Wang Z, Ma X, Wang C
Neuropsychiatric Disease and Treatment 2019, 15:1649-1657
Published Date: 24 June 2019
The efficacy of a “cocktail therapy” on Parkinson’s disease with dementia
Zhang C, Zang Y, Song Q, Li H, Hu L, Zhao W, Feng S, Gu F, Zhao F, Zhang C
Neuropsychiatric Disease and Treatment 2019, 15:1639-1647
Published Date: 24 June 2019
Correlation between precontemplation and alpha activity in gambling disorder
Lee J, Choi SW, Kim KM, Lee YS, Kim JW
Neuropsychiatric Disease and Treatment 2019, 15:1629-1637
Published Date: 21 June 2019
Machine learning techniques in a structural and functional MRI diagnostic approach in schizophrenia: a systematic review
de Filippis R, Carbone EA, Gaetano R, Bruni A, Pugliese V, Segura-Garcia C, De Fazio P
Neuropsychiatric Disease and Treatment 2019, 15:1605-1627
Published Date: 19 June 2019
Symptomatic stability with aripiprazole once-monthly: efficacy analyses from acute and long-term studies
Madera JJ, Such P, Zhao C, Baker RA
Neuropsychiatric Disease and Treatment 2019, 15:1593-1604
Published Date: 18 June 2019
Status epilepticus in patients with genetic (idiopathic) generalized epilepsy
Bosak M, Pawełczak D, Słowik A
Neuropsychiatric Disease and Treatment 2019, 15:1585-1592
Published Date: 20 June 2019
Serum lipid profiles and post-stroke depression in acute ischemic stroke patients
Shen H, Tu X, Luan X, Zeng Y, He J, Tang W
Neuropsychiatric Disease and Treatment 2019, 15:1573-1583
Published Date: 17 June 2019
Prospective memory in non-psychotic first-degree relatives of patients with schizophrenia: a meta-analysis
Lin SZ, Wu YK, Su YA, Si TM
Neuropsychiatric Disease and Treatment 2019, 15:1563-1571
Published Date: 7 June 2019
Incidental intracranial pathology: a retrospective case review of structural neuroimaging results amongst young adult psychiatric patients
LeBaron DB, Mahjoub Y, Abba-Aji A
Neuropsychiatric Disease and Treatment 2019, 15:1557-1562
Published Date: 7 June 2019
The effect of stimulants on irritability in autism comorbid with ADHD: a systematic review
Ghanizadeh A, Molla M, Olango GJ
Neuropsychiatric Disease and Treatment 2019, 15:1547-1555
Published Date: 6 June 2019
COMT polymorphism regulates the hippocampal subfield volumes in first-episode, drug-naive patients with major depressive disorder
Otsuka Y, Kakeda S, Sugimoto K, Katsuki A, Nguyen LH, Igata R, Watanabe K, Ueda I, Kishi T, Iwata N, Korogi Y, Yoshimura R
Neuropsychiatric Disease and Treatment 2019, 15:1537-1545
Published Date: 6 June 2019
Pharmacological treatment of negative symptoms in schizophrenia: update and proposal of a clinical algorithm
Cerveri G, Gesi C, Mencacci C
Neuropsychiatric Disease and Treatment 2019, 15:1525-1535
Published Date: 5 June 2019
A virtual reality application for assessment for attention deficit hyperactivity disorder in school-aged children
Fang Y, Han D, Luo H
Neuropsychiatric Disease and Treatment 2019, 15:1517-1523
Published Date: 4 June 2019
Combination of the CAGE and serum gamma-glutamyl transferase: an effective screening tool for alcohol use disorder and alcohol dependence
Choe YM, Lee BC, Choi IG, Suh GH, Lee DY, Kim JW
Neuropsychiatric Disease and Treatment 2019, 15:1507-1515
Published Date: 31 May 2019
GABAB receptor activation ameliorates spatial memory impairments in stress-exposed rats
Sahraei H, Askaripour M, Esmaeilpour K, Shahsavari F, Rajabi S, Moradi-Kor N
Neuropsychiatric Disease and Treatment 2019, 15:1497-1506
Published Date: 30 May 2019
Patient and physician perceptions of disease management in Parkinson’s disease: results from a US-based multicenter survey
Hermanowicz N, Castillo-Shell M, McMean A, Fishman J, D’Souza J
Neuropsychiatric Disease and Treatment 2019, 15:1487-1495
Published Date: 30 May 2019
Melatonin receptor agonists—ramelteon and melatonin—for bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials
Kishi T, Nomura I, Sakuma K, Kitajima T, Mishima K, Iwata N
Neuropsychiatric Disease and Treatment 2019, 15:1479-1486
Published Date: 30 May 2019
Cross-sectional study of psychiatric comorbidities in patients with atopic dermatitis and nonatopic eczema, urticaria, and psoriasis
Ahn HJ, Shin MK, Seo JK, Jeong SJ, Cho AR, Choi SH, Lew BL
Neuropsychiatric Disease and Treatment 2019, 15:1469-1478
Published Date: 28 May 2019
HO-1 protects the nerves of rats with cerebral hemorrhage by regulating the PI3K/AKT signaling pathway
Zhao Q, Qu R, Teng L, Yin C, Yuan Y
Neuropsychiatric Disease and Treatment 2019, 15:1459-1468
Published Date: 28 May 2019
Drug-use patterns and severe adverse events with disease-modifying drugs in patients with multiple sclerosis: a cohort study based on German claims data
Simbrich A, Thibaut J, Khil L, Berger K, Riedel O, Schmedt N
Neuropsychiatric Disease and Treatment 2019, 15:1439-1457
Published Date: 28 May 2019
Neuroprotection by 2,3,5,4ʹ-tetrahydroxystilbene-2-O-β-D-glucoside extracts from Polygonum multiflorum against cerebral ischemia/reperfusion injury through the 5-hydroxytryptamine/5-hydroxytryptamine receptor pathway
Yi CA, Wang J, Wang Y, Wu XY
Neuropsychiatric Disease and Treatment 2019, 15:1429-1438
Published Date: 27 May 2019
Efficacy of light therapy on nonseasonal depression among elderly adults: a systematic review and meta-analysis [Corrigendum]
Chang CH, Liu CY, Chen SJ, Tsai HC
Neuropsychiatric Disease and Treatment 2019, 15:1427-1428
Published Date: 27 May 2019
Clinical association of vitamin D and serotonin levels among patients with fibromyalgia syndrome
Amin OA, Abouzeid SM, Ali SA, Amin BA, Alswat KA
Neuropsychiatric Disease and Treatment 2019, 15:1421-1426
Published Date: 27 May 2019
The relationship between serum cobalamin, folic acid, and homocysteine and the risk of post-cardiac surgery delirium
Vahdat Shariatpanahi M, Velayati A, Jamalian SA, Babevaynejad M, Vahdat Shariatpanahi Z
Neuropsychiatric Disease and Treatment 2019, 15:1413-1419
Published Date: 23 May 2019
Antidepressant, anti-inflammatory, and antioxidant effects of electroacupuncture through sonic hedgehog–signaling pathway in a rat model of poststroke depression
Cai W, Ma W, Wang GT, Li YJ, Shen WD
Neuropsychiatric Disease and Treatment 2019, 15:1403-1411
Published Date: 23 May 2019
Vascular cognitive impairment: pathophysiological mechanisms, insights into structural basis, and perspectives in specific treatments
Parfenov VA, Ostroumova OD, Ostroumova TM, Kochetkov AI, Fateeva VV, Khacheva KK, Khakimova GR, Epstein OI
Neuropsychiatric Disease and Treatment 2019, 15:1381-1402
Published Date: 21 May 2019
Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia
Mathews M, Gopal S, Nuamah I, Hargarter L, Savitz AJ, Kim E, Tan W, Soares B, Correll CU
Neuropsychiatric Disease and Treatment 2019, 15:1365-1379
Published Date: 21 May 2019
Structural changes in white matter lesion patients and their correlation with cognitive impairment
Wang J, Liang Y, Chen H, Wang W, Wang Y, Liang Y, Zhang Y
Neuropsychiatric Disease and Treatment 2019, 15:1355-1363
Published Date: 21 May 2019
What are the links between hypoxia and Alzheimer’s disease?
Lall R, Mohammed R, Ojha U
Neuropsychiatric Disease and Treatment 2019, 15:1343-1354
Published Date: 21 May 2019
Cognitive impairment in eating disorder patients of short and long-term duration: a case–control study
Grau A, Magallón-Neri E, Faus G, Feixas G
Neuropsychiatric Disease and Treatment 2019, 15:1329-1341
Published Date: 21 May 2019
Risk factors for delirium: are therapeutic interventions part of it?
Xing J, Yuan Z, Jie Y, Liu Y, Wang M, Sun Y
Neuropsychiatric Disease and Treatment 2019, 15:1321-1327
Published Date: 17 May 2019
A patient with Korsakoff syndrome of psychiatric and alcoholic etiology presenting as DSM-5 mild neurocognitive disorder
Nikolakaros G, Kurki T, Myllymäki A, Ilonen T
Neuropsychiatric Disease and Treatment 2019, 15:1311-1320
Published Date: 22 May 2019
Cardiac dysautonomia in depression – heart rate variability biofeedback as a potential add-on therapy
Pinter A, Szatmari Jr S, Horvath T, Penzlin AI, Barlinn K, Siepmann M, Siepmann T
Neuropsychiatric Disease and Treatment 2019, 15:1287-1310
Published Date: 17 May 2019
Binge eating in patients with polycystic ovary syndrome: prevalence, causes, and management strategies
Krug I, Giles S, Paganini C
Neuropsychiatric Disease and Treatment 2019, 15:1273-1285
Published Date: 16 May 2019
Deep brain stimulation in the treatment of obsessive-compulsive disorder: current perspectives
Tastevin M, Spatola G, Régis J, Lançon C, Richieri R
Neuropsychiatric Disease and Treatment 2019, 15:1259-1272
Published Date: 15 May 2019
Cognitive impairment in depression: recent advances and novel treatments
Perini G, Cotta Ramusino M, Sinforiani E, Bernini S, Petrachi R, Costa A
Neuropsychiatric Disease and Treatment 2019, 15:1249-1258
Published Date: 10 May 2019
Quality and utilization of the Finnish clinical practice guideline in schizophrenia: evaluation using AGREE II and the vignette approach
Vähäniemi A, Välimäki M, Pekurinen V, Anttila M, Lantta T
Neuropsychiatric Disease and Treatment 2019, 15:1239-1248
Published Date: 9 May 2019
Rumination, posttraumatic stress disorder, and mood symptoms in borderline personality disorder
Dell’Osso L, Cremone IM, Carpita B, Dell’Oste V, Muti D, Massimetti G, Barlati S, Vita A, Fagiolini A, Carmassi C, Gesi C
Neuropsychiatric Disease and Treatment 2019, 15:1231-1238
Published Date: 13 May 2019
Chronic stress increases susceptibility to food addiction by increasing the levels of DR2 and MOR in the nucleus accumbens
Wei NL, Quan ZF, Zhao T, Yu XD, Xie Q, Zeng J, Ma FK, Wang F, Tang QS, Wu H, Zhu JH
Neuropsychiatric Disease and Treatment 2019, 15:1211-1229
Published Date: 8 May 2019
Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial
Rodríguez C, García T, Areces D, Fernández E, García-Noriega M, Domingo JC
Neuropsychiatric Disease and Treatment 2019, 15:1193-1209
Published Date: 8 May 2019
The prognosis and changes of regional brain gray matter volume in MDD with gastrointestinal symptoms
Liu P, Li G, Zhang A, Sun N, Kang L, Yang C, Wang Y, Zhang K
Neuropsychiatric Disease and Treatment 2019, 15:1181-1191
Published Date: 9 May 2019
The relationships between video game experience and cognitive abilities in adolescents
Özçetin M, Gümüştaş F, Çağ Y, Gökbay İZ, Özmel A
Neuropsychiatric Disease and Treatment 2019, 15:1171-1180
Published Date: 8 May 2019
Negative Facebook experiences among Taiwanese gay and bisexual men in emerging adulthood: associations with traditional harassment victimization and quality of life
Lu WH, Chang YP, Lin CH, Yen CF
Neuropsychiatric Disease and Treatment 2019, 15:1163-1170
Published Date: 6 May 2019
Health, functionality, and social support in families with a child with a neurodevelopmental disorder – a pilot study
Cavonius-Rintahaka D, Aho AL, Voutilainen A, Billstedt E, Gillberg C
Neuropsychiatric Disease and Treatment 2019, 15:1151-1161
Published Date: 8 May 2019
Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial
Zhuo K, Tang Y, Song Z, Wang Y, Wang J, Qian Z, Li H, Xiang Q, Chen T, Yang Z, Xu Y, Fan X, Wang J, Liu D
Neuropsychiatric Disease and Treatment 2019, 15:1141-1150
Published Date: 8 May 2019
Personality associated with depressive status in individuals with type 2 diabetes mellitus
Yasui-Furukori N, Murakami H, Otaka H, Nakayama H, Murabayashi M, Mizushiri S, Matsumura K, Tanabe J, Matsuhashi Y, Yanagimachi M, Nakamura K, Daimon M, Sugawara N
Neuropsychiatric Disease and Treatment 2019, 15:1133-1139
Published Date: 3 May 2019
Effects of transection of cervical sympathetic trunk on cognitive function of traumatic brain injury rats
Long J, He CJ, Dai H, Kang XG, Zou JF, Ye SL, Yu Q
Neuropsychiatric Disease and Treatment 2019, 15:1121-1131
Published Date: 3 May 2019
Detection of cognitive impairment using a machine-learning algorithm [Corrigendum]
Youn YC, Choi SH, Shin HW, Kim KW, Jang JW, Jung JJ, Hsiung GY, Kim SY
Neuropsychiatric Disease and Treatment 2019, 15:1119-1120
Published Date: 1 May 2019
Effect of pre- and post-treatment with Bacopa monnieri (Brahmi) on phencyclidine-induced disruptions in object recognition memory and cerebral calbindin, parvalbumin, and calretinin immunoreactivity in rats
Piyabhan P, Tingpej P, Duansak N
Neuropsychiatric Disease and Treatment 2019, 15:1103-1117
Published Date: 1 May 2019
The association between CD157/BST1 polymorphisms and the susceptibility of Parkinson’s disease: a meta-analysis
Li J, Luo J, Liu L, Fu H, Tang L
Neuropsychiatric Disease and Treatment 2019, 15:1089-1102
Published Date: 30 April 2019
Metabonomics reveals peripheral and central short-chain fatty acid and amino acid dysfunction in a naturally occurring depressive model of macaques
Deng F, Pan J, Zheng P, Xia J, Yin B, Liang W, Li Y, Wu J, Xu F, Wu Q, Qu C, Li W, Wang H, Xie P
Neuropsychiatric Disease and Treatment 2019, 15:1077-1088
Published Date: 1 May 2019
Deep brain stimulation in Tourette’s syndrome: evidence to date
Casagrande SCB, Cury RG, Alho EJL, Fonoff ET
Neuropsychiatric Disease and Treatment 2019, 15:1061-1075
Published Date: 29 April 2019
The modern perspective for long-acting injectables antipsychotics in the patient-centered care of schizophrenia
Pietrini F, Albert U, Ballerini A, Calò P, Maina G, Pinna F, Vaggi M, Boggian I, Fontana M, Moro C, Carpiniello B
Neuropsychiatric Disease and Treatment 2019, 15:1045-1060
Published Date: 30 April 2019
2D-DIGE as a strategy to identify serum protein biomarkers to monitor pharmacological efficacy in dopamine-dictated states of Parkinson’s disease and schizophrenia
Gupta AK, Kumar GK, Rani K, Pokhriyal R, Khan MI, Kumar DR, Goyal V, Tripathi M, Gupta R, Chadda RK, Vanamail P, Mohanty AK, Hariprasad G
Neuropsychiatric Disease and Treatment 2019, 15:1031-1044
Published Date: 24 April 2019
Aldehyde dehydrogenase 2 rs671G>A polymorphism and ischemic stroke risk in Chinese population: a meta-analysis
Xu YL, Hu YY, Li JW, Zhou L, Li L, Niu YM
Neuropsychiatric Disease and Treatment 2019, 15:1015-1029
Published Date: 23 April 2019
The influence of non-breathing-related sleep fragmentation on cognitive function in patients with cerebral small vessel disease
Wang J, Chen X, Liao J, Zhou L, Liao S, Shan Y, Lu Z, Tao J
Neuropsychiatric Disease and Treatment 2019, 15:1009-1014
Published Date: 18 April 2019
The association of neutrophil-to-lymphocyte ratio and delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage: possible involvement of cerebral blood perfusion
Wu Y, He Q, Wei Y, Zhu J, He Z, Zhang XD, Guo ZD, Xu R, Cheng C, Huang Z, Sun XC
Neuropsychiatric Disease and Treatment 2019, 15:1001-1007
Published Date: 26 April 2019
Association study of the excitatory amino acid transporter 2 (EAAT2) and glycine transporter 1 (GlyT1) gene polymorphism with schizophrenia in a Polish population
Merk W, Kucia K, Mędrala T, Kowalczyk M, Owczarek A, Kowalski J
Neuropsychiatric Disease and Treatment 2019, 15:989-1000
Published Date: 24 April 2019
Abnormal resting-state functional connectivity of amygdala subregions in patients with obstructive sleep apnea
Yu H, Chen L, Li H, Xin H, Zhang J, Wei Z, Peng D
Neuropsychiatric Disease and Treatment 2019, 15:977-987
Published Date: 17 April 2019
Self-perception of mental illness, and subjective and objective cognitive functioning in people with schizophrenia
Chuang SP, Wu JY, Wang CS
Neuropsychiatric Disease and Treatment 2019, 15:967-976
Published Date: 23 April 2019
Early symptom non-improvement and aggravation are associated with the treatment response to SSRIs in MDD: a real-world study
Yuan H, Zhu X, Luo Q, Halim A, Halim M, Yao H, Cai Y, Shi S
Neuropsychiatric Disease and Treatment 2019, 15:957-966
Published Date: 16 April 2019
Unilateral thalamic glioma disrupts large-scale functional architecture of human brain during resting state
Li S, Gao L, Liu Y, Ao Y, Xu H
Neuropsychiatric Disease and Treatment 2019, 15:947-956
Published Date: 15 April 2019
Cortical thinning and flattening in schizophrenia and their unaffected parents
Yan J, Cui Y, Li Q, Tian L, Liu B, Jiang T, Zhang D, Yan H
Neuropsychiatric Disease and Treatment 2019, 15:935-946
Published Date: 12 April 2019
Effects of repetitive magnetic stimulation on the growth of primarily cultured hippocampus neurons in vitro and their expression of iron-containing enzymes
Wang Y, Fang K, He S, Fan Y, Yu J, Zhang X
Neuropsychiatric Disease and Treatment 2019, 15:927-934
Published Date: 11 April 2019
Minimally invasive evacuation of spontaneous supratentorial intracerebral hemorrhage by transcranial neuroendoscopic approach
Cai Q, Guo Q, Li Z, Wang W, Zhang W, Ji B, Chen Z, Liu J
Neuropsychiatric Disease and Treatment 2019, 15:919-925
Published Date: 11 April 2019
A meta-analysis of levetiracetam for randomized placebo-controlled trials in patients with refractory epilepsy
Chen D, Bian H, Zhang L
Neuropsychiatric Disease and Treatment 2019, 15:905-917
Published Date: 11 April 2019
Fluvoxamine treatment response prediction in obsessive-compulsive disorder: association rule mining approach
Hasanpour H, Ghavamizadeh Meibodi R, Navi K, Shams J, Asadi S, Ahmadiani A
Neuropsychiatric Disease and Treatment 2019, 15:895-904
Published Date: 10 April 2019
Effects of early HIV infection and combination antiretroviral therapy on intrinsic brain activity: a cross-sectional resting-state fMRI study
Li R, Wang W, Wang Y, Peters S, Zhang X, Li H
Neuropsychiatric Disease and Treatment 2019, 15:883-894
Published Date: 10 April 2019
Objective diagnosis of post-stroke depression using NMR-based plasma metabonomics
Hu Z, Fan S, Liu M, Zhong J, Cao D, Zheng P, Wang Y, Wei Y, Fang L, Xie P
Neuropsychiatric Disease and Treatment 2019, 15:867-881
Published Date: 10 April 2019
Fear of cancer recurrence, anxiety and depressive symptoms in adolescent and young adult cancer patients
Sun H, Yang Y, Zhang J, Liu T, Wang H, Garg S, Zhang B
Neuropsychiatric Disease and Treatment 2019, 15:857-865
Published Date: 8 April 2019
Lifetime predictors of stroke in subjects without a diagnosis of hypertension: the aerobics center longitudinal study
Cavero-Redondo I, Sui X, Blair SN, Lavie CJ, Álvarez-Bueno C, Martínez-Vizcaíno V
Neuropsychiatric Disease and Treatment 2019, 15:849-856
Published Date: 8 April 2019
Proton magnetic resonance spectroscopy changes in a longitudinal schizophrenia study: a pilot study in eleven patients
Galińska-Skok B, Szulc A, Małus A, Konarzewska B, Cwalina U, Tarasów E, Waszkiewicz N
Neuropsychiatric Disease and Treatment 2019, 15:839-847
Published Date: 8 April 2019
Therapeutic strategies in the early stages of Parkinson’s disease: a cross-sectional evaluation of 15 years’ experience with a large cohort of Romanian patients
Szász JA, Orbán-Kis K, Constantin VA, Péter C, Bíró I, Mihály I, Szegedi K, Balla A, Szatmári S
Neuropsychiatric Disease and Treatment 2019, 15:831-838
Published Date: 5 April 2019
Cognitive function, depression, and anxiety in patients undergoing radical prostatectomy with and without adjuvant treatment
Jarzemski P, Brzoszczyk B, Popiołek A, Stachowicz-Karpińska A, Gołota S, Bieliński M, Borkowska A
Neuropsychiatric Disease and Treatment 2019, 15:819-829
Published Date: 5 April 2019
Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy
Kuga A, Otsubo T, Tsuji T, Hayashi S, Imagawa H, Fujikoshi S, Escobar R
Neuropsychiatric Disease and Treatment 2019, 15:809-817
Published Date: 5 April 2019
Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3)
Zajecka JM, Stanford AD, Memisoglu A, Martin WF, Pathak S
Neuropsychiatric Disease and Treatment 2019, 15:795-808
Published Date: 4 April 2019
Overcoming barriers to effective management of tardive dyskinesia
Caroff SN
Neuropsychiatric Disease and Treatment 2019, 15:785-794
Published Date: 4 April 2019
Genetic polymorphisms in Sox17 associated with intracranial aneurysm in Chinese Han people: a genotype-phenotype study
Li M, Wang W, Zhang L, Xin W, Zhao Y, Huan L, Yu J, Zhang H, Zhang J, Yang S, Liang D, Yang W, Yang X
Neuropsychiatric Disease and Treatment 2019, 15:779-783
Published Date: 2 April 2019
Anti-N-methyl-D-aspartate receptor encephalitis mimics neuroleptic malignant syndrome: case report and literature review
Wang HY, Li T, Li XL, Zhang XX, Yan ZR, Xu Y
Neuropsychiatric Disease and Treatment 2019, 15:773-778
Published Date: 2 April 2019
Sleep problems in children with autism spectrum disorder: clinical correlates and the impact of attention deficit hyperactivity disorder
Gunes S, Ekinci O, Feyzioglu A, Ekinci N, Kalinli M
Neuropsychiatric Disease and Treatment 2019, 15:763-771
Published Date: 2 April 2019
Preliminary comparison of neuropsychological performance in patients with non-small-cell lung cancer treated with chemotherapy or targeted therapy
Kang HL, Chen VCH, Hung WL, Hsiao HP, Wang WH
Neuropsychiatric Disease and Treatment 2019, 15:753-761
Published Date: 28 March 2019
Relationships between Internet addiction and clinicodemographic and behavioral factors
ElSalhy M, Miyazaki T, Noda Y, Nakajima S, Nakayama H, Mihara S, Kitayuguchi T, Higuchi S, Muramatsu T, Mimura M
Neuropsychiatric Disease and Treatment 2019, 15:739-752
Published Date: 26 March 2019
Predictors of achieving remission in schizophrenia patients treated with paliperidone palmitate 3-month formulation
Nash AI, Turkoz I, Savitz AJ, Mathews M, Kim E
Neuropsychiatric Disease and Treatment 2019, 15:731-737
Published Date: 22 March 2019
Pleiotropic action of genetic variation in ZNF804A on brain structure: a meta-analysis of magnetic resonance imaging studies
Wang S, He Y, Chen Z, Li Y, Zhao J, Lyu L
Neuropsychiatric Disease and Treatment 2019, 15:721-729
Published Date: 21 March 2019
Impaired comprehension of metaphorical expressions in very mild Alzheimer’s disease
Fujimoto N, Nakamura H, Tsuda T, Wakutani Y, Takao T
Neuropsychiatric Disease and Treatment 2019, 15:713-720
Published Date: 20 March 2019
Repetitive transcranial magnetic stimulation in trauma-related conditions
Namgung E, Kim M, Yoon S
Neuropsychiatric Disease and Treatment 2019, 15:701-712
Published Date: 19 March 2019
Identification of key genes, pathways and miRNA/mRNA regulatory networks of CUMS-induced depression in nucleus accumbens by integrated bioinformatics analysis
Ma K, Zhang HX, Wei GH, Dong ZF, Zhao HJ, Han XC, Song XB, Zhang HL, Zong X, Baloch Z, Wang SJ
Neuropsychiatric Disease and Treatment 2019, 15:685-700
Published Date: 14 March 2019
The association of maternal diabetes with attention deficit and hyperactivity disorder in offspring: a meta-analysis
Zhao L, Li X, Liu G, Han B, Wang J, Jiang X
Neuropsychiatric Disease and Treatment 2019, 15:675-684
Published Date: 12 March 2019
Effects of prenatal exposure to temephos on behavior and social interaction
Martins Laurentino AO, Durante de Medeiros F, de Oliveira J, da Rosa N, Mateus Gomes T, de Medeiros Peretti E, Somariva Prophiro J, Fortunato JJ
Neuropsychiatric Disease and Treatment 2019, 15:669-673
Published Date: 11 March 2019
Effects of melatonin in children with attention-deficit/hyperactivity disorder with sleep disorders after methylphenidate treatment
Masi G, Fantozzi P, Villafranca A, Tacchi A, Ricci F, Ruglioni L, Inguaggiato E, Pfanner C, Cortese S
Neuropsychiatric Disease and Treatment 2019, 15:663-667
Published Date: 7 March 2019
GSK-3β and BDNF genes may not be associated with venlafaxine treatment response in Chinese of Han ethnicity
Sun Q, Yuan F, Ren D, Ma G, Yang F, Wu X, He L, He G
Neuropsychiatric Disease and Treatment 2019, 15:657-661
Published Date: 7 March 2019
Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations [Corrigendum]
Mayerova M, Ustohal L, Jarkovsky J, Pivnicka J, Kasparek T, Ceskova E
Neuropsychiatric Disease and Treatment 2019, 15:655-656
Published Date: 5 March 2019
Odor perception and hedonics in chronic schizophrenia and in first episode psychosis
Urban-Kowalczyk M, Strzelecki D, Śmigielski J, Kotlicka-Antczak M
Neuropsychiatric Disease and Treatment 2019, 15:647-654
Published Date: 5 March 2019
Vascular risk modulates the relationship between cerebral amyloid deposition and subjective memory complaints
Kim JW, Byun MS, Yi D, Lee JH, Ko K, Jung G, Lee DY
Neuropsychiatric Disease and Treatment 2019, 15:637-645
Published Date: 4 March 2019
Prevalence and outcomes of Guillain-Barré syndrome among pediatrics in Saudi Arabia: a 10-year retrospective study
Asiri S, Altwaijri WA, Ba-Armah D, Al Rumayyan A, Alrifai MT, Salam M, Almutairi AF
Neuropsychiatric Disease and Treatment 2019, 15:627-635
Published Date: 1 March 2019
Social cognitive training for adults with Noonan syndrome: a feasibility study
Roelofs RL, Wingbermühle E, Kessels RPC, Egger JIM
Neuropsychiatric Disease and Treatment 2019, 15:611-626
Published Date: 26 February 2019
Racial and ethnic differences in depression: current perspectives
Bailey RK, Mokonogho J, Kumar A
Neuropsychiatric Disease and Treatment 2019, 15:603-609
Published Date: 22 February 2019
Efficacy and safety of paliperidone palmitate 3-month versus 1-month formulation in patients with schizophrenia: comparison between European and non-European population
Savitz AJ, Xu H, Gopal S, Nuamah I, Ravenstijn P, Hough D, Hargarter L
Neuropsychiatric Disease and Treatment 2019, 15:587-602
Published Date: 21 February 2019
Evaluation of plasma levels of neopterin and soluble CD40 ligand in patients with acute ischemic stroke in upper Egypt: can they surrogate the severity and functional outcome?
Tony AA, Tony EAE, Mohammed WS, Kholef EF
Neuropsychiatric Disease and Treatment 2019, 15:575-586
Published Date: 22 February 2019
Neurocognitive mechanisms of theory of mind impairment in neurodegeneration: a transdiagnostic approach
Strikwerda-Brown C, Ramanan S, Irish M
Neuropsychiatric Disease and Treatment 2019, 15:557-573
Published Date: 20 February 2019
Clinical feature and outcome of late-onset cobalamin C disease patients with neuropsychiatric presentations: a Chinese case series
Wang S, Yan C, Wen B, Zhao Y
Neuropsychiatric Disease and Treatment 2019, 15:549-555
Published Date: 21 February 2019
Aripiprazole for the treatment of psychotic symptoms in patients with dementia with Lewy bodies: a case series
Sugawara Kikuchi Y, Shimizu T
Neuropsychiatric Disease and Treatment 2019, 15:543-547
Published Date: 22 February 2019
Histamine H3 receptor antagonist E177 attenuates amnesia induced by dizocilpine without modulation of anxiety-like behaviors in rats
Alachkar A, Khan N, Łażewska D, Kieć-Kononowicz K, Sadek B
Neuropsychiatric Disease and Treatment 2019, 15:531-542
Published Date: 20 February 2019
The interactive effects of stress and coping style on cognitive function in patients with schizophrenia
Zhu X, Xu X, Xu C, Zhang J, Zhang X, Ma L, Liu J, Wang K
Neuropsychiatric Disease and Treatment 2019, 15:523-530
Published Date: 21 February 2019
Diabetes and elevated preoperative HbA1c level as risk factors for postoperative delirium after cardiac surgery: an observational cohort study
Kotfis K, Szylińska A, Listewnik M, Brykczyński M, Ely EW, Rotter I
Neuropsychiatric Disease and Treatment 2019, 15:511-521
Published Date: 20 February 2019
Bipolar spectrum disorders and associated factors among adults attending an antiretroviral therapy clinic in Gedeo zone health centers, southern Ethiopia
Belayneh Z, Alemu W, Mekuriaw B, Abebe Z
Neuropsychiatric Disease and Treatment 2019, 15:503-509
Published Date: 20 February 2019
Aberrant attentive and inattentive brain activity to auditory negative words, and its relation to persecutory delusion in patients with schizophrenia
Iwashiro N, Takano Y, Natsubori T, Aoki Y, Yahata N, Gonoi W, Kunimatsu A, Abe O, Kasai K, Yamasue H
Neuropsychiatric Disease and Treatment 2019, 15:491-502
Published Date: 14 February 2019
Stimuli may have little impact on the deficit of visual working memory accuracy in first-episode schizophrenia
She S, Zhang B, Mi L, Li H, Kuang Q, Bi T, Zheng Y
Neuropsychiatric Disease and Treatment 2019, 15:481-489
Published Date: 18 February 2019
Radio electric asymmetric conveyer neuromodulation in depression, anxiety, and stress
Rinaldi A, Rinaldi C, Coelho Pereira JA, Lotti Margotti M, Bittencourt MN, Barcessat ARP, Fontani V, Rinaldi S
Neuropsychiatric Disease and Treatment 2019, 15:469-480
Published Date: 13 February 2019
Durability of symptomatic responses obtained with adjunctive vagus nerve stimulation in treatment-resistant depression
Kumar A, Bunker MT, Aaronson ST, Conway CR, Rothschild AJ, Mordenti G, Rush AJ
Neuropsychiatric Disease and Treatment 2019, 15:457-468
Published Date: 13 February 2019
Role of paliperidone palmitate 3-monthly in the management of schizophrenia: insights from clinical practice
Lopez A, Rey J
Neuropsychiatric Disease and Treatment 2019, 15:449-456
Published Date: 11 February 2019
Addenbrooke's cognitive examination III in the diagnosis of dementia: a critical review
Bruno D, Schurmann Vignaga S
Neuropsychiatric Disease and Treatment 2019, 15:441-447
Published Date: 15 February 2019
The effect of night shift on sleep quality and depressive symptoms among Chinese nurses
Dai C, Qiu H, Huang Q, Hu P, Hong X, Tu J, Xie Q, Li H, Ren W, Ni S, Chen F
Neuropsychiatric Disease and Treatment 2019, 15:435-440
Published Date: 7 February 2019
Stimulus intensity determined by dose-titration versus age-based methods in electroconvulsive therapy in Thai patients
Ittasakul P, Likitnukul A, Pitidhammabhorn U, Waleeprakhon P, Goldman MB
Neuropsychiatric Disease and Treatment 2019, 15:429-434
Published Date: 7 February 2019
Analysis of motor performance in individuals with cerebral palsy using a non-immersive virtual reality task – a pilot study
Martins FPA, Massetti T, Crocetta TB, Bianchi Lopes P, da Silva AA, Figueiredo EF, de Abreu LC, da Silva TD, Monteiro CBM
Neuropsychiatric Disease and Treatment 2019, 15:417-428
Published Date: 4 February 2019
HDAC4 gene silencing alleviates epilepsy by inhibition of GABA in a rat model
Zhang YN, Dong HT, Duan L, Niu L, Yuan GQ, Dai JQ, Hou BR, Pan YW
Neuropsychiatric Disease and Treatment 2019, 15:405-416
Published Date: 4 February 2019
Mild cognitive decline in type 2 diabetes mellitus patients – risk factors and pathogenesis: role of DPP4 activity and future possible therapeutic targets
Gul O, Gul S
Neuropsychiatric Disease and Treatment 2019, 15:403-404
Published Date: 4 February 2019
Psychiatric comorbidities in patients with intentional methanol intoxication
Yang WS, Yen TH, Juang YY, Lee SH, Wang BH, Lee CP
Neuropsychiatric Disease and Treatment 2019, 15:397-402
Published Date: 31 January 2019
Clinical factors influencing resilience in patients with anorexia nervosa
Kane C, Tomotake M, Hamatani S, Chiba S, Kameoka N, Watanabe S, Nakataki M, Numata S, Ohmori T
Neuropsychiatric Disease and Treatment 2019, 15:391-395
Published Date: 30 January 2019
Evacuation of chronic and subacute subdural hematoma via transcranial neuroendoscopic approach
Cai Q, Guo Q, Zhang F, Sun D, Zhang W, Ji B, Chen Z, Mao S
Neuropsychiatric Disease and Treatment 2019, 15:385-390
Published Date: 30 January 2019
Genetic effects on white matter integrity in drug-naive patients with major depressive disorder: a diffusion tensor imaging study of 17 genetic loci associated with depressive symptoms
Kakeda S, Watanabe K, Katsuki A, Sugimoto K, Ueda I, Igata N, Kishi T, Iwata N, Abe O, Yoshimura R, Korogi Y
Neuropsychiatric Disease and Treatment 2019, 15:375-383
Published Date: 29 January 2019
Hyperbaric oxygen therapy attenuates neuronal apoptosis induced by traumatic brain injury via Akt/GSK3β/β-catenin pathway
He H, Li X, He Y
Neuropsychiatric Disease and Treatment 2019, 15:369-374
Published Date: 25 January 2019
Lack of association between ALOX5AP genetic polymorphisms and risk of ischemic stroke: evidence from meta-analyses
Zheng J, Ning G, Xu W, Wen X, Ma X
Neuropsychiatric Disease and Treatment 2019, 15:357-367
Published Date: 25 January 2019
A novel approach to cardiovascular disturbances in patients with schizophrenia spectrum disorders treated with long-acting injectable medication
Andor M, Dehelean L, Romosan AM, Buda V, Radu G, Caruntu F, Bordejevic A, Manea MM, Papava I, Bredicean CA, Romosan RS, Tomescu M
Neuropsychiatric Disease and Treatment 2019, 15:349-355
Published Date: 25 January 2019
The association between HTR1B gene rs13212041 polymorphism and onset of alcohol abuse
Svob Strac D, Nedic Erjavec G, Nikolac Perkovic M, Nenadic-Sviglin K, Konjevod M, Grubor M, Pivac N
Neuropsychiatric Disease and Treatment 2019, 15:339-347
Published Date: 24 January 2019
Effects of early administration of insulin-like growth factor-1 on cognitive function in septic encephalopathy
Yang Y, Liang S, Li Y, Gao F, Cao Y, Zhao X, Gao G, Li L
Neuropsychiatric Disease and Treatment 2019, 15:323-337
Published Date: 23 January 2019
Depressed mood induction in early cigarette withdrawal is unaffected by acute monoamine precursor supplementation
Dowlati Y, de Jesus DR, Selby P, Fan I, Meyer JH
Neuropsychiatric Disease and Treatment 2019, 15:311-321
Published Date: 23 January 2019
Cytokines and chemokines expression in serum of patients with neuromyelitis optica
Ai NP, Liu HJ, Zhou HF, Lin DH, Wang JQ, Yang M, Song HG, Sun MM, Xu QG, Wei SH
Neuropsychiatric Disease and Treatment 2019, 15:303-310
Published Date: 21 January 2019
Negative and positive self-thoughts predict subjective quality of life in people with schizophrenia
Takeda T, Nakataki M, Ohta M, Hamatani S, Matsuura K, Yoshida R, Kameoka N, Tominaga T, Umehara H, Kinoshita M, Watanabe S, Numata S, Sumitani S, Ohmori T
Neuropsychiatric Disease and Treatment 2019, 15:293-301
Published Date: 21 January 2019
Altered intrinsic brain activity in patients with toothaches using the amplitude of low-frequency fluctuations: a resting-state fMRI study
Yang J, Li B, Yu QY, Ye L, Zhu PW, Shi WQ, Yuan Q, Min YL, He YL, Shao Y
Neuropsychiatric Disease and Treatment 2019, 15:283-291
Published Date: 18 January 2019
Frequency-dependent neural activity in primary angle-closure glaucoma
Jiang F, Yu C, Zuo MJ, Zhang C, Wang Y, Zhou FQ, Zeng XJ
Neuropsychiatric Disease and Treatment 2019, 15:271-282
Published Date: 18 January 2019
Association between anxious distress in a major depressive episode and bipolarity
Sugawara H, Tsutsumi T, Inada K, Ishigooka J, Hashimoto M, Takebayashi M, Nishimura K
Neuropsychiatric Disease and Treatment 2019, 15:267-270
Published Date: 15 January 2019
Serum BICC1 levels are significantly different in various mood disorders
Chen S, Jiang H, Xu Z, Zhao J, Wang M, Lu Y, Li J, Sun F, Yuan Y
Neuropsychiatric Disease and Treatment 2019, 15:259-265
Published Date: 15 January 2019
Brexpiprazole for the maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy
Ward K, Citrome L
Neuropsychiatric Disease and Treatment 2019, 15:247-257
Published Date: 15 January 2019
Reliability and validity of the Depression and Somatic Symptoms Scale among patients with chronic low back pain
Liu CH, Fu TS, Lee CP, Hung CI
Neuropsychiatric Disease and Treatment 2019, 15:241-246
Published Date: 14 January 2019
Disturbances of mitochondrial parameters to distinguish patients with depressive episode of bipolar disorder and major depressive disorder
Zvěřová M, Hroudová J, Fišar Z, Hansíková H, Kališová L, Kitzlerová E, Lambertová A, Raboch J
Neuropsychiatric Disease and Treatment 2019, 15:233-240
Published Date: 14 January 2019
Lower vitamin D levels are associated with depression in patients with gout
Zhou Q, Shao Y, Gan Z, Fang L
Neuropsychiatric Disease and Treatment 2019, 15:227-231
Published Date: 14 January 2019
Health-related quality of life and its correlates in Japanese patients with myotonic dystrophy type 1
Endo M, Odaira K, Ono R, Kurauchi G, Koseki A, Goto M, Sato Y, Kon S, Watanabe N, Sugawara N, Takada H, Kimura E
Neuropsychiatric Disease and Treatment 2019, 15:219-226
Published Date: 14 January 2019
Association analysis of polymorphisms in STARD6 and near ECHDC3 in Alzheimer’s disease patients carrying the APOE ε4 Allele
Yin J, Feng W, Yuan H, Yuan J, Wu Y, Liu X, Jin C, Cheng Z
Neuropsychiatric Disease and Treatment 2019, 15:213-218
Published Date: 11 January 2019
Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan
Sugawara N, Kudo S, Ishioka M, Sato Y, Kubo K, Yasui-Furukori N
Neuropsychiatric Disease and Treatment 2019, 15:205-211
Published Date: 9 January 2019
Prevalence and associated factors of comorbid anxiety disorders in late-life depression: findings from geriatric tertiary outpatient settings
Suradom C, Wongpakaran N, Wongpakaran T, Lerttrakarnnon P, Jiraniramai S, Taemeeyapradit U, Lertkachatarn S, Arunpongpaisal S
Neuropsychiatric Disease and Treatment 2019, 15:199-204
Published Date: 7 January 2019
Effectiveness of 1-year treatment with long-acting formulation of aripiprazole, haloperidol, or paliperidone in patients with schizophrenia: retrospective study in a real-world clinical setting
Di Lorenzo R, Ferri P, Cameli M, Rovesti S, Piemonte C
Neuropsychiatric Disease and Treatment 2019, 15:183-198
Published Date: 7 January 2019
The impact of short and long sleep duration on instrumental activities of daily living among stroke survivors
Seixas AA, Chung DP, Richards SL, Madhavaram S, Raghavan P, Gago J, Casimir G, Jean-Louis G
Neuropsychiatric Disease and Treatment 2019, 15:177-182
Published Date: 4 January 2019
Risk factors for developing dementia in type 2 diabetes mellitus patients with mild cognitive impairment
Albai O, Frandes M, Timar R, Roman D, Timar B
Neuropsychiatric Disease and Treatment 2019, 15:167-175
Published Date: 3 January 2019
Risk factors for the difficulties in general activities across the day in Chinese children and adolescents with attention-deficit/hyperactivity disorder
Ke X, Du Y, Zheng Y, Su L, Chen Y, Zhang YL, Chen K, Cheng Y, Chen W
Neuropsychiatric Disease and Treatment 2019, 15:157-166
Published Date: 31 December 2018
Association between the SLC6A4 gene and schizophrenia: an updated meta-analysis
Xu F, Wang B, Yao J
Neuropsychiatric Disease and Treatment 2019, 15:143-155
Published Date: 28 December 2018
Differences in etiological beliefs about schizophrenia among patients, family, and medical staff
Tarakita N, Yoshida K, Sugawara N, Kubo K, Furukori H, Fujii A, Nakamura K, Yasui-Furukori N
Neuropsychiatric Disease and Treatment 2019, 15:137-142
Published Date: 27 December 2018
Effects of cerebrolysin on functional outcome of patients with traumatic brain injury: a systematic review and meta-analysis
Ghaffarpasand F, Torabi S, Rasti A, Niakan MH, Aghabaklou S, Pakzad F, Beheshtian MS, Tabrizi R
Neuropsychiatric Disease and Treatment 2019, 15:127-135
Published Date: 27 December 2018
Frequent attenders in general medical practice in Italy: a preliminary report on clinical variables related to low functioning
Carmassi C, Dell’Oste V, Ceresoli D, Moscardini S, Bianchi E, Landi R, Massimetti G, Nisita C, Dell’Osso L
Neuropsychiatric Disease and Treatment 2019, 15:115-125
Published Date: 24 December 2018
A literature-based algorithm for the assessment, management, and monitoring of drug-induced QTc prolongation in the psychiatric population
Zolezzi M, Cheung L
Neuropsychiatric Disease and Treatment 2019, 15:105-114
Published Date: 24 December 2018
Poststroke epilepsy: current perspectives on diagnosis and treatment
Sarecka-Hujar B, Kopyta I
Neuropsychiatric Disease and Treatment 2019, 15:95-103
Published Date: 24 December 2018
Associations of BRAP polymorphisms with the risk of alcohol dependence and scores on the Alcohol Use Disorders Identification Test
Kim JW, Choe YM, Shin JG, Park BL, Shin HD, Choi IG, Lee BC
Neuropsychiatric Disease and Treatment 2019, 15:83-94
Published Date: 24 December 2018
Intrinsic thalamocortical connectivity varies in the age of onset subtypes in major depressive disorder
Brown EC, Clark DL, Hassel S, MacQueen G, Ramasubbu R
Neuropsychiatric Disease and Treatment 2019, 15:75-82
Published Date: 21 December 2018
Treatment of acute thromboembolic complication after stent-assisted coil embolization of ruptured intracranial aneurysm: a case report
Xu N, Meng H, Liu T, Feng Y, Qi Y, Wang H
Neuropsychiatric Disease and Treatment 2019, 15:69-74
Published Date: 21 December 2018
The factor structure, reliability and validity of the Chinese version of the Van Dream Anxiety Scale
Wang X, Dai L, Yin M, Deng YL
Neuropsychiatric Disease and Treatment 2019, 15:57-67
Published Date: 21 December 2018
Association between CD14 rs2569190 C>T polymorphism and ischemic stroke susceptibility: a meta-analysis based on 5,277 subjects
Wu YQ, Cheng SY, Xu XC, Li WC
Neuropsychiatric Disease and Treatment 2019, 15:47-55
Published Date: 21 December 2018
Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies
Thase ME, Weiller E, Zhang P, Weiss C, McIntyre RS
Neuropsychiatric Disease and Treatment 2019, 15:37-45
Published Date: 20 December 2018
Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm
Dong H, Fan S, Luo Y, Peng B
Neuropsychiatric Disease and Treatment 2019, 15:33-36
Published Date: 19 December 2018
Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles
Yi ZM, Wen C, Cai T, Xu L, Zhong XL, Zhan SY, Zhai SD
Neuropsychiatric Disease and Treatment 2019, 15:1-19
Published Date: 17 December 2018